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CHAPTER 1 – Intraoperative Awareness: Incidence, Epidemiology, Risk 
Factors, and Consequences 
Experiencing and remembering the trauma of surgery is a feared complication and is 
often referred to as intraoperative awareness or anesthesia awareness (AWR).  “Awareness” in 
this context is defined as the consciousness and explicit recall of events during an operation 
(between time of anesthesia induction and emergence from anesthesia) that can include auditory, 
sensory, and/or nociceptive stimuli.  AWR occurs while a patient is intended to be under general 
anesthesia (GA).  GA is defined as a drug-induced loss of consciousness during which a patient 
cannot be aroused even by a painful stimulus (ASA Task Force, 2006).   A balanced anesthetic 
technique can include the use of amnesic drugs, neuromuscular blocking agents (paralytics), 
narcotics, and inhaled or intravenous anesthetics.  These medications are titrated to maintain 
stable physiologic parameters based on the patient’s co-morbidities.   
The incidence of AWR is low and reported to be between 0.1 – 0.2%.  Sebel et al. 
demonstrated an incidence of 0.13% (Sebel et al., 2004) for definite AWR at seven medical 
centers in the United States, which is consistent with an earlier study in Europe finding an 
incidence of 0.16% (Sandin et al., 2000).  Collectively, these studies suggest an incidence of 
approximately 1-2cases/1000. However, if the potential or possible AWR reports in the Sebel et 
al. study were included, the incidence rose to 0.36% (Sebel et al., 2004).  In high-risk cases the 
incidence may be as high as 1%.   
The incidence of AWR changes in different healthcare environments around the world.  
Ranta et al. investigated all patients undergoing GA for a one year period in Finland and found 
an incidence of 0.4% of definite AWR and an incidence of 0.3% for possible AWR (Ranta et al., 
1998).  They noted that the AWR patients received a statistically smaller dose of anesthetics 
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based on hand review of the medical records.  Psychiatric evaluations were performed on five of 
the AWR patients and it was determined that three of the five patients had a history of major 
depression (Ranta et al., 1998).  Myles et al. performed a patient satisfaction survey the first day 
after an operation in Australia and noted a self-reported AWR incidence similar to the United 
States of 0.11% (Myles et al., 2000).  More recently, Errando et al. prospectively evaluated 4,001 
patients in Spain and noted a very high incidence of 1.0% which is about 5 times that of the 
reported rate in the United States (Errando et al., 2008).  Xu et al. conducted a descriptive cohort 
study from 25 medical centers in China which included data on 11,101 patients (Xu et al., 2009).  
They showed an incidence of 0.41% of definite AWR and 0.41% of possible AWR cases which 
is about double the reported rate in the United States.  The United Kingdom and Irish pubic 
hospitals have performed national audits on the event of “accidental awareness” (Pandit et al., 
2014).  The most recent NAP5 (5th National Audit Project) used a patient reporting system of 
accidental AWR over a one year time period and reported an incidence of certain or probable and 
possible AWR cases of 1 out of every 19,600 anesthetics (Pandit et al., 2014).  The NAP5 
project is different from the other previously described studies since this was a self-reporting 
system by the patient with no specific constraints on the time of the report in relation to the 
operation and no formal interviews conducted.   
Data derived from internal quality assurance or improvement programs have also been 
retrospectively analyzed to determine the incidence of anesthesia AWR.  Pollard et al. used data 
from a quality improvement program over a three year period (2002-2004) at eight locations to 
investigate the incidence of AWR (Pollard et al., 2007).  Patients were interviewed within a 48 
hour window after GA.  They reported a far lower incidence of awareness across the 8 
participating centers:  0.0068% or 1 of every 14,560 patients (Pollard et al., 2007).  Mashour et 
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al. in turn also reviewed three years of quality assurance data at a large academic institution 
(Mashour et al., 2009c).  Patients were interviewed on post-operative day one following 
anesthesia by a member of the anesthesia team or a nurse via a postoperative interview.  Patients 
were not specifically asked about AWR but rather a general open ended question regarding 
problems with anesthesia.  They found a higher incidence than Pollard et al. (2007) of 0.023% or 
1 of every 4,401 patients (Mashour et al., 2009c).  Mashour et al. highlighted that the 
retrospective approach was likely insufficient for optimal capture of awareness events (Mashour 
et al., 2009c).  Mashour et al. resolved the controversies in the literature regarding AWR 
incidence by comparing prospective, structured interviews and spontaneous patient reports in a 
single cohort.  They found a significantly higher capture for awareness events with structured 
interviews (Mashour et al., 2013). 
In the United States there are approximately 21 million patients that receive general 
anesthesia per year, which equates to 20,000 to 40,000 associated cases of AWR (JACHO, 
2004).  Even though AWR is a low incidence event, due to the large number of general 
anesthetics performed each year there is a significant number of patients adversely affected.  The 
literature states a complex list of experiences reported by patients during the awareness event 
including: auditory perceptions, visual perceptions, tactile stimuli, pain, paralysis, helplessness, 
anxiety, fear, extreme panic, terror and feeling of abandonment  (Cook et al., 2014; Domino et 
al., 1999; Ghoneim et al., 2009; Moerman et al., 1993; Osterman et al., 2001; Schwender et al., 
1998).  After the event, patients report anxiety, nightmares, unpleasant dreams, flashbacks, and 
post-traumatic stress disorder (PTSD) (Cook et al., 2014; Domino et al., 1999; Ghoneim et al., 
2009; Moerman et al., 1993; Osterman et al., 2001; Schwender et al., 1998).  The Joint 
Commission on Accreditation of Hospital Organizations reviewed the literature on AWR and 
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reported 48% related to auditory stimuli, 48% percent related to the sensation of not being able 
to breathe and 28% related to pain (JACHO, 2004).  Several small cohort samples have also been 
reported in the literature.  Moerman et al. noted that 70% of the patients studied experienced 
sleep disturbances, nightmares, flashbacks and anxiety due to the awareness experience 
(Moerman et al., 1993).  Schwender et al. (interviewed 45 awareness patients from Germany and 
noted that 22 of the 45 patients experienced negative unpleasant effects after the event 
(Schwender et al., 1998).  Mashour et al. have developed a classification instrument to aid the 
analysis of qualitative experiences, as well as the experience of distress during an anesthesia 
awareness event (Mashour et al., 2010).   
Patients who do experience explicit awareness have reported significant psychological 
sequelae including posttraumatic stress disorder (PTSD).  PTSD is developed after a traumatic 
experience and has three significant components; re-experiencing of the event, avoidance of cues 
or triggers related to the event, and physiological hyperarousal (Osterman et al., 2001; Whitlock 
et al., 2014).   There is significant emotional, social, and economic impact of patients with 
psychological sequelae following an intraoperative AWR event and therefore the need to 
minimize such events (although rare) is important in the medical community.   From a small 
cohort report of awareness patients, PTSD was shown in 3 of 45 patients (Schwender et al., 
1998).  The patients were interviewed on average 0.84 years (range 0.1-5.0) after the AWR event 
(Schwender et al., 1998).  Osterman et al. sought to determine the development of PTSD after 
AWR by investigating 16 AWR patients and 10 control patients (Osterman et al., 2001).  All 
patients were administered the Clinician Administered PTSD Scale (CAPS) (Blake et al., 1995).  
CAPS scores patients on a scale from 0 to 136 (Blake et al., 1995).  A score 45 or greater meets 
the diagnostic criteria for PTSD (Blake et al., 1995).  Osterman et al. found that 56.3% of the 
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AWR patients and no control patients met the diagnostic criteria for PTSD (Osterman et al., 
2001).  Of the PTSD patients, the patients met the criteria with an average 17.9 years after the 
event (Osterman et al., 2001).  Three factors were significantly associated with developing 
PTSD; intraoperative experience “that you left your body at some point” and “that at some point 
you could mentally escape” as well as postoperative feeling “that you left your body at some 
point” (Osterman et al., 2001).  Osterman et al. and Schwender et al. both determined that 
patients experience PTSD years after the actual awareness event (Osterman et al., 2001; 
Schwender et al., 1998).  Leslie et al. further validated the high incidence of PTSD after 
awareness and showed an incidence of 71% (Leslie et al., 2010).  The Psychological Sequelae of 
Surgery (Psych SOS) study used a cohort of AWR patients from three large clinical trials 
investigating the prevention of AWR with control patients on age, sex, type of surgery, and risk 
of AWR (Whitlock et al., 2014).  A total of 68 AWR patients were matched with 418 control 
patients and were administered the PTSD Checklist-Specific (PCL-S) and/ or the modified Mini 
International Neuropsychiatric Interview with a median time of two years past the date of the 
operation.  These techniques were aimed at identifying patients that exhibited symptoms of 
PTSD (Whitlock et al., 2014).  Whitlock et al. demonstrated 43% of patients with AWR met the 
criteria for PTSD using the PCL-S and 14% of the AWR patients scored consistently with the 
DSM-IV diagnosis of PTSD (Whitlock et al., 2014).  More recently, the NAP5 reported that 47% 
of their self-reported AWR cases were associated with distress to the patient (Cook et al., 2014).  
Since the NAP5 is the most recent study on negative experiences of patients that experience 
AWR, the actual incidence of PTSD is unknown.  However, the authors did state that via patient 
self-report experiences of “re-experiencing the event through ‘flashbacks’ and nightmares, 
hyperarousal (increased anxiety, sleep disturbances) and avoidance” (Cook et al., 2014).  
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Therefore, it is not unreasonable to conclude that some of these patients have or will develop 
PTSD after the AWR event.  Thus, there are serious consequences to AWR that highlight the 
need for its prevention.  
To date no prospective large scale clinical trials have been performed to determine 
independent risk factors for an AWR event.  However, quality assurance closed claims databases 
have been examined to try to identify such risk factors retrospectively.   Domino et al. reviewed 
the national database from the American Society of Anesthesiologists Closed Claims Project 
(Domino et al., 1999).  This database is a compilation of closed medical claims from the United 
States.  Although this not an inclusive list of all AWR cases seen in the United States it is 
representative of the type of patients who seek a malpractice claim.  Of the 4,183 claims 
reviewed, 1.5% were due to a complaint of awareness (Domino et al., 1999).  Women (77%) and 
patients under 60 years of age (89%) were more likely to file an AWR claim (Domino et al., 
1999).  The majority of patients (68%) who filed an AWR claim were healthy (American Society 
of Anesthesiologists class I or II on a I-V scale) and undergoing elective surgery (87%) (Domino 
et al., 1999).  After review of the medical records that were available, Domino et al. determined 
that 33% of the AWR patients received standard of care while a surprising 43% received sub-
standard care (Domino et al., 1999).  A logistic regression model was developed to look for 
independent risk factors associated with malpractice claims of AWR.  They found that using no 
volatile anesthetic (adjusted odds ratio (AOR) 3.20 95% confidence interval (CI) 1.88-5.46), 
female gender (AOR 3.08, 95% CI 1.58-6.06), intraoperative opioid use (AOR 2.12, 95% CI 
1.20-3.74) and intraoperative muscle relaxant use (AOR 2.28, 95% CI 1.22-4.25) were 
independent predictors of AWR claims (Domino et al., 1999).  Although these data are 
interesting, Domino’s work is limited to only those cases that actually filed a complaint and 
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therefore is not a complete picture of all types of patients who have had an experience of AWR 
and therefore the independent predictors may not translate to a representative sample. More 
recently, NAP5 also contributed to the literature potential risk factors based on the 300 self-
reported events of AWR.  They noted that factors that may pre-dispose a patient to AWR were: 
females (65% of reports), younger adults, obesity (3-fold effect), level of training of the 
anesthesiologist, history of awareness during a previous anesthetic, operations not occurring 
during normal business hours, emergent operations, obstetric surgery, cardiothoracic surgery, 
and the use of neuromuscular blockade agents during the operation (Pandit et al., 2014).  Due to 
the small sample size of AWR patients within the NAP5, no predictive modeling could be 
performed.  However, when comparing Domino’s study using closed claimed data and the NAP5 
both female sex and the use of neuromuscular blockade during the case are documented as 
potential indicators that put patients at risk for AWR.   
Since so little is known about the mechanisms, true incidence, and risk factors of 
anesthesia awareness, the Joint Commission on Accreditation of Hospital Organizations issued a 
sentinel event on anesthesia awareness in 2004 and noted that “Anesthesia awareness is under-
recognized and under-treated in health care organizations” (JACHO, 2004).  The Joint 
Commission recommends the development and implementation of AWR policies to educate 
clinicians, develop a risk profile to determine high risk patients, and discuss the risk factors with 
patients prior to undergoing anesthesia.  They also recommend use of effective anesthesia 
monitoring tools and appropriate post-operative follow-up by the anesthesiology team for all 
patients that undergo a general anesthetic.  For patients that do have a documented explicit AWR 
event, the Joint Commission recommends the facilitation of proper counseling avenues.  In 2006, 
the American Society of Anesthesiologists (ASA) followed the Joint Commission and developed 
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a task force to “stimulate the pursuit and evaluation of strategies that may prevent or reduce the 
frequency of intraoperative awareness and provide guidance for the intraoperative use of brain 
function monitors as they relate to intraoperative awareness” (ASA Task Force, 2006).   
Causes of Intraoperative Awareness 
There are several main causes of AWR documented in the literature from previously 
described cases; overly “light” anesthesia (87% of AWR cases), increased anesthetic 
requirements (7% of AWR cases) and malfunction (5% of AWR cases) or misuse of anesthesia 
delivery systems (4% of AWR cases) (Ghoneim et al., 2009).  The NAP5 also introduced several 
additional potential causes of AWR; the use of neuromuscular blocking drugs (93% of AWR 
cases) without the use of a nerve stimulator to monitor the actual muscular blockade (9% of 
AWR cases used the nerve stimulator), type of anesthetic agents used to induce GA, and total 
intravenous anesthesia (Pandit et al., 2014). 
Light anesthesia is necessary in some types of surgical cases (such as trauma) or when 
the patient is not medically tolerant of the anesthetic dose but the operation is emergent 
(Ghoneim, 2010).  However, light anesthesia can also occur by error in the delivery system with 
either mechanical malfunction or the clinician not being aware that there is insufficient 
anesthetic delivery (Ghoneim, 2010).  Situations associated with an inability to tolerate normal 
doses of anesthesia include high risk patients (ASA class IV or V), hypovolemia, patients with 
limited cardiac reserve, cardiac or trauma operations, and cesarean sections (Ghoneim, 2010).    
Some patients require higher than normal anesthetics requirements.  Age and 
hypothermia affect the minimum alveolar concentration (MAC), which is commonly used as a 
tool to determine adequate anesthesia.  The MAC decreases by approximately 6% per decade of 
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age (Mapleson, 1996).  MAC was also determined to be lower for two commonly used inhaled 
anesthetics (halothane and isoflurane) in hypothermic piglets (Satas et al., 1996).  Recently a 
distinct phenotype (red hair) has been linked to a specific genotype demonstrating that red-haired 
patients require significantly more inhaled anesthetic requirements (desflurane) than dark-haired 
patients (Liem et al., 2004).  Smith et al. found that rodents showed a rapid tolerance to the 
inhalational anesthetic nitrous oxide, a phenomenon referred to as tachyphylaxis (Smith et al., 
1979).  Research on rodents has also shown that chronic exposure to sub-anesthetic doses of 
nitrous oxide causes tolerance, which is no longer seen six days after the termination of exposure 
(Koblin et al., 1979).  For humans, an acute tolerance to nitrous oxide within 10 to 60 minutes of 
administration was shown in some patients but the reason was not clear (Ramsay et al., 1992).  
From the pharmacologic perspective, chronic alcohol and opioid use also increase requirements 
(McQuay et al., 1982; Shafer et al., 1983; Tammisto and Takki, 1973).  Tammisto and Takki 
reviewed the records of 151 chronic alcoholics and determined that they required higher doses of 
anesthetics and also 20% of the patients exhibited signs of inadequate anesthesia (Tammisto and 
Takki, 1973).  Arguably, the most important reason for a patient’s increase for anesthetic 
requirements is a history of AWR (Aranake et al., 2013; Ghoneim et al., 2009).  Aranake et al. 
demonstrated a relative risk of 5.0 (95% Confidence Interval 1.3-19.9) to experience another 
AWR event when a patient had a history of AWR (Aranake et al., 2013).  Patients with a history 
of AWR from three clinical trials focused on AWR prevention were matched with patients who 
did not have a history (Avidan et al., 2011; Avidan et al., 2008; Mashour et al., 2012); 
importantly, the control group patients also had at least one risk factor for AWR.  
The malfunction or misuse of anesthesia delivery systems are generally due to either lack 
of servicing, neglect of the care provider to check for proper machine functionality prior to use, 
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and lack of vigilance by the anesthesia care provider. Increased vigilance of the anesthesia care 
provider has been shown in one study to decrease the incidence of AWR in cardiac surgery 
patients (Ranta et al., 1996).   Ranta et al. performed a two phase study to address vigilance and 
anesthesia awareness (Ranta et al., 1996).  In phase one, patients were interviewed to determine 
the incidence and identify the patients who experienced AWR.   These findings were reported 
back to the care providers for high risk cardiac patients including the administration of 
anesthetics given.  For phase two of the study they interviewed patients for documented AWR 
and noted a decrease in the incidence from 4% to 1.5% between the two phases (Ranta et al., 
1996).  Ranta et al. concluded that with education and increased vigilance the documented 
incidence rate in a high risk population can be decreased (Ranta et al., 1996).   
There are also several risk factors in addition to the stated known causes that also will put 
a patient at increased risk for AWR: duration of laryngoscopy and intubation, history of difficult 
intubation or anticipated difficult intubation, chronic pain patient presenting using high dose 
opioids, planned use of relaxants during the maintenance of GA, absence of volatile anesthetic or 
propofol use during maintenance of anesthesia (Ghoneim et al., 2009) and total intravenous 
anesthesia (ASA Task Force, 2006; Ghoneim, 2010; Pandit et al., 2014). 
Techniques for Monitoring Anesthetic Depth: MAC and EEG 
 The first public demonstration of a surgery under GA occurred in 1846 and 
approximately one year later the “stages” of GA were described by Snow. The stages of 
anesthesia essentially used the patient as the “monitor,” basing anesthetic depth on respiratory 
patterns, muscle tone, and pupillary responses.  Because the stages of anesthesia were 
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qualitative, the potency of anesthetic drugs could not be readily compared to one another 
(Mashour, 2006).   
In 1965 a turning point for modern anesthesia arose with the concept of minimum 
alveolar concentration (MAC).  MAC was developed as a way to quantify the anesthetic effect of 
inhalational agents (Eger et al., 1965).  MAC is defined as the minimum alveolar concentration 
of inhaled anesthetic that will prevent movement from a noxious stimulus in 50% of subjects 
(Eger et al., 1965).  This concept worked well to quantify differences between different 
inhalational anesthetics (anesthetic vapors), as potency could be related to a single behavioral 
endpoint.   
MAC is defined in terms of one atmospheric pressure and serves as an indicator for the 
concentration of the anesthetic (Gelb, 2009).  Specifically, the MAC represents the partial 
pressure of the inhaled anesthetic vapor in the alveoli of the lungs (Gelb, 2009; Quasha et al., 
1980). When the partial pressure of any vapor is at equilibrium in the body, all tissues of the 
body will have the same partial pressure of the vapor, including the alveoli of the lung, the brain, 
and the blood (Quasha et al., 1980).  Therefore, the MAC is a representation of the partial 
pressure of the vapor in the brain but not the actual concentration of the vapor (Quasha et al., 
1980).   However, the measurement of the expired partial pressure of the anesthetic vapor is 
proportional to the actual anesthetic concentration affecting the brain of the specific anesthetic 
vapor (Gelb, 2009). 
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To calculate the MAC for a specific time-point for a specific inhaled anesthetic vapor: 
(Eger, 2001; Gelb, 2009; Quasha et al., 1980).   
MAC =  End-tidal expired partial pressure (captured by the attached gas analyzer) 
    Known MAC value constant for that specific inhaled anesthetic vapor  
The MAC for each specific inhaled anesthetic vapor is set for the age of 40.  However, 
MAC decreased by decade of life and therefore the MAC is age adjusted depending on the age of 
the patient (Eger, 2001; Gelb, 2009; Mashour et al., 2009a; Quasha et al., 1980).   
Some common limitations of MAC are: neuromuscular blockade that is commonly used 
during surgery obscures the behavioral endpoint of MAC, MAC is specific to inhaled agents, and 
anesthetic effects on mobility are mediated 
in the spinal cord rather than the brain 
(Mashour, 2006).  In regards to anesthetic 
monitoring to minimize the probability of 
consciousness, MAC is not directly related 
to the neuroanatomic substrate of 
consciousness (Mashour, 2006).   However, 
MAC monitoring is the standard of care 
currently for measuring depth of anesthesia.  
Since MAC has limitations, this has led to a 
renewed interest in electroencephalographic 
(EEG) assessment of anesthetic depth, which was suggested by Gibbs et al. in 1937 (Gibbs, 
1937). 
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EEG monitoring was the next logical step for assessing anesthetic depth because while 
MAC is a pharmacologic measure, the EEG reflects activity of the end-organ of interest, the 
brain.  The EEG signal on the scalp is from the synaptic activity of the pyramidal cells in the 
superficial layers of the cerebral cortex (Figure 1) (Olejniczak, 2006; Rampil, 1998; Sloan, 2006; 
Teplan, 2002; Walczak, 2009).  Pyramidal cells are a major neuronal cell type in the cortex.  
They have a long straight dendrite that extends from the cell body up through the cortical layers 
directly to the surface of the pial surface of the gyrus (Jameson and Sloan, 2006; Rampil, 1998; 
Teplan, 2002; Walczak, 2009).  If the neighboring pyramidal cells have similar altered 
membrane potentials they combine additively in the extracellular fluid to create a larger current 
flow that is detected on the scalp (Olejniczak, 2006; Rampil, 1998; Sloan, 2006; Teplan, 2002; 
Walczak, 2009).  Therefore, pyramidal cells can be affected by other local synaptic activity as 
well as from other neural activity, specifically from the thalamus (Jameson and Sloan, 2006; 
Sloan, 2006; Teplan, 2002; Walczak, 2009).  The EEG electrodes on the scalp register changes 
in voltage, which can fluctuate with changes in the current that flows between the dendrites and 
the cortical pyramidal cells (Olejniczak, 2006; Sloan, 2006; Teplan, 2002; Voss and Sleigh, 
2007; Walczak, 2009).  The voltages are attenuated and smeared by the passage through the 
cranium and the scalp, which in turn will allow higher voltages to become dominant readings on 
the EEG (Voss and Sleigh, 2007).  Therefore, the EEG monitors used for depth of anesthesia 
monitoring report a frequency-distorted measure of mean dendritic currents of cortical pyramidal 
neurons (Sloan, 2006; Teplan, 2002; Voss and Sleigh, 2007; Walczak, 2009).   
There are five EEG frequency bands that are influenced by anesthetic administration: 
gamma, beta, alpha, theta and delta.  Gamma waves (25-50 Hz) are traditionally associated with 
higher cognition and the processing of sensory stimulation in the awake brain (Jameson and 
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Sloan, 2006; John and Prichep, 2005).  Beta waves (12-24 Hz) are traditionally associated with 
the alert state (Freye and Levy, 2005; Sloan, 2006).  Alpha waves (8-12 Hz) are seen when 
patients are awake but with their eyes closed or in a relaxed state (Freye and Levy, 2005; 
Jameson and Sloan, 2006; Sloan, 2006; Teplan, 2002).  Theta waves (4-8 Hz) are normally seen 
in sleep (Freye and Levy, 2005; Jameson and Sloan, 2006; Sloan, 2006).  Delta waves (below 4 
Hz) are traditionally demonstrated in deep sleep (Jameson and Sloan, 2006; Sloan, 2006).  
The changes in EEG patterns are drug specific and not consistent across all anesthetics.  
Numerous studies have been conducted to determine how commonly used anesthetics affect the 
EEG.  Long et al. investigated the EEG determinants of 14 patients emerging from GA with 
thiopental, nitrous oxide-oxygen, and vecuronium and supplemented either isoflurane (inhaled) 
or fentanyl (intravenous) (Long et al., 1989).  Patients in the supplemented isoflurane group 
showed “obvious changes” in their EEG before the patient responded to verbal commands to 
open their eyes (Long et al., 1989).  This was not seen in patients supplemented with fentanyl 
during emergence of GA (Long et al., 1989).  Long et al. concluded that when using isoflurane, 
EEG determinants can be used to guide when a patient will emerge from GA but not when a 
fentanyl-supplemented GA is used (Long et al., 1989).  Drummond et al. investigated the median 
frequency, spectral edge frequency, frequency band power ratio, total power, and dominance 
shift of the EEG recording to determine if one specific component can be a predictor of the depth 
of anesthesia during the emergence phase from isoflurane-nitrous oxide based anesthesia in 15 
surgical patients (Drummond et al., 1991).  The conclusion was that no one specific component 
of the EEG can be used as predictor for the depth of anesthesia and that at best, the EEG 
components can only be used as a trend when used in conjunction with other commonly used 
clinical signs to measure the depth of anesthesia (Drummond et al., 1991). Sebel et al. 
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investigated movement on surgical incision (noxious stimuli) in patients with GA induced with 
thiopental but maintained with three different MACs of isoflurane and found that for patients 
who did not move, there was a statistically significant difference in their delta power on the EEG 
(Sebel et al., 1995).  Rundshaen et al. further validated the change in the delta power on the EEG 
during intubation (noxious stimuli) when thiopental and fentanyl were used (Rundshagen et al., 
2004).  Sakai et al. sought to investigate the use of ketamine and propofol infusions in 48 
patients. Patients received either propofol infusion or ketamine plus propofol infusion in varying 
doses.  They concluded that when ketamine is included with propofol, less propofol is needed to 
have clinical significant endpoints for hypnosis (Sakai et al., 1999).  Although the addition of 
ketamine decreases the dose of propofol to reach hypnosis endpoints, it did not depress the EEG 
in proportion to the hypnotic effects (Sakai et al., 1999).  Gamma waves were shown to be 
significantly decreased when propofol induction was used in surgical patients, whereas ketamine 
had the opposite effect (Lee et al., 2009).  Ketamine increased the power in the gamma 
bandwidth and decreased the power in the alpha wave on the EEG (Lee et al., 2013).    In human 
subjects, alpha oscillations appear prominently in the occipital lobe in the resting state with eyes 
closed.  However, alpha power and coherence is reduced in the occipital lobe and increased in 
the frontal lobes in association with propofol-induced unconsciousness (Purdon et al., 2013).  
This reverses with return of consciousness.  Propofol and sevoflurane, when used as a GA for 
maintenance of anesthesia, both demonstrated alpha oscillations on the EEG (Akeju et al., 2014).  
Sevoflurane, but not propofol, demonstrated increased power in the theta component of the EEG 
(Akeju et al., 2014).   The evidence presented suggests that there is not one specific component 
of the EEG that changes uniformly under anesthesia that could serve as the sole predictor of the 
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depth of anesthesia.  Therefore, when using the EEG, either processed or un-processed, the type 
of anesthetic used must be considered when interpreting the relevant changes in the EEG. 
EEG Transformation to Bispectral Analysis for Anesthesia Depth Monitoring 
 The EEG is one of several voltage waveforms present on the scalp of a patient.  In the 
awake patient there is an electrocardiogram (ECG) from the carotid artery in the neck, 
electromyography (EMG) from the muscles of the face, and electrooculography (EOG) from the 
muscles around the eye.  The patient’s body also acts as an antenna and the different voltage 
waveforms interact with the EEG.  Therefore, a well-designed amplifier is needed to remove or 
attenuate the unwanted signals.  For example, the EMG has some overlap with the EEG in the 
gamma bandwidth.  To rectify this, the raw EEG tracing is amplified and then put through a 
band-pass filter to quantify and separate the EEG from the EMG.  Some depth of anesthesia 
monitors report the EMG with the EEG.   
 Signal processing is mandatory to remove any artifacts that are attributable to other 
electrical activities. For the EEG, an analog signal must be transformed into a digital signal.  By 
definition, analog signals are continuous and smooth where digital signals represent discrete 
points in time and the values are set to a specific time point (Rampil, 1998).  The EEG varies 
smoothly over a set time and is therefore an analog signal on the scalp (Rampil, 1998).  When an 
analog signal is translated to digital, it occurs at a specific time point (sampling interval) which is 
known as sampling or digitizing (Figure 2) (Schwilden, 2006).  There is a loss of fidelity of the 
smooth continuous EEG signal when digitizing occurs at set specific time points.  The number of 
time points is selected using a sample rate (expressed in hertz (Hz)) which is the reciprocal of the 
sampling interval (Rampil, 1998).  The sampling interval is determined using Nyquist-Shannon’s 
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sampling theorem which states that the sampling rate should be more than twice the highest 
expected frequency of the EEG signal (Rampil, 1998; Schwilden, 2006).  Current systems that 
process EEG from an analog 
to a digital signal recommend 
setting a sampling rate that is 
4 to 10 time higher than the 
highest expected frequency as 
well as to use a low pass filter 
(high frequency filter) to 
remove any frequencies 
outside the known range of 
EEG frequencies (0.5-30 Hz) 
(Rampil, 1998; Sloan, 2006; 
Walczak, 2009).   
 A time domain analysis is one way to analyze the EEG by examining how the voltage 
changes over time (Rampil, 1998; Sigl and Chamoun, 1994).  Any signal can be expressed in 
terms of its sinusoids components (sin and cosine waves) (Sigl and Chamoun, 1994).  The sin 
and cosine wave can be expressed as a function of time, t, and described by their amplitude, 
frequency and phase angle with the formula: (Rampil, 1998; Sigl and Chamoun, 1994) 
 x(t) = amplitude * sin [phase angle + 2π(frequency)(time)] 
where: amplitude = one half the peak to peak voltage 
 frequency = number of complete cycles per second 
phase angle = offset of the wave signal from time 0 
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Complex EEG waveforms which may represent all five common frequencies bands can 
be transformed from the time domain to a frequency domain using Fourier transformation (or 
spectral analysis) based off of Fourier’s 
Theorem (Rampil, 1998; Sigl and 
Chamoun, 1994; Tonner and Scholz, 2006).   
Fourier’s Theorem allows any waveform to 
be shown as the sum of its respective sin 
waves with different frequencies, 
amplitudes, and phase angles (Walczak, 
2009).  The Fourier Transformation is 
composed of discrete points that correspond 
to a specific frequency (Equation 1) (Sigl 
and Chamoun, 1994).  The range of the 
frequency for equation one is determined by 
the sampling rate (ƒs) and will span from a 
frequency of 0 to ƒs/2 (Sigl and Chamoun, 
1994).  Every component frequency will 
have a power.  The frequency domain 
transformation is normally presented graphically as the magnitude of the frequency that 
component contributed to the signal (or power).  The power of each component is then used to 
compute the power spectrum (Equation 2) (Sigl and Chamoun, 1994).  The result of the Fourier 
transformation, with the power spectrum, is the generation of a frequency spectrum as a function 
of power (Figure 3), which will allow the user to quantify the extent to which frequency 
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components are present in the EEG signal (Freye and Levy, 2005; Rampil, 1998; Sigl and 
Chamoun, 1994; Tonner and Scholz, 2006). Fourier transformation is quite laborious, even with 
a computer, so in 1965 Cooley 
and Tukey published an algorithm 
for Fourier series computation of 
digitized data, which was called 
Fast Fourier Transformation and 
is now used for processing of 
EEG signals (Freye and Levy, 
2005; Rampil, 1998).  
 Since the EEG is a 
complex signal and is non-linear 
in nature, one sinusoid 
component may interact with 
another sinusoid component and 
therefore is not a function of just 
one frequency.  This interaction 
is referred to as phase coupling.  
For example, assume a simple 
non-linear system where the 
output is the square of the input 
signal (Equation 3) (Sigl and 
Chamoun, 1994).  In the output, (ƒ1 + ƒ2), (ƒ1 - ƒ2), 2ƒ1, and 2ƒ2 are all dependent on the input 
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signal ƒ1 and ƒ2.  Therefore, these are termed intermodulation products (IMP) (Sigl and 
Chamoun, 1994).  The corresponding phase angles of the IMP output signal are also dependent 
on the input signal and are termed phase coupled.  Phase coupling implies that the sinusoidal 
components may have a common generator (Rampil, 1998).  Phase coupling is typical in the 
brain and you can use the degree of phase coupling to investigate relationships in changes to the 
level of sedation seen with the use of anesthetics.  To quantify the amount of phase coupling in 
the system, a bispectral analysis is performed, which reflects the phase coupling across two 
frequencies (Hagihira et al., 2001).   
The bispectrum of the EEG measures the correlation of phases between different 
frequency components and quantifies the relationship among three sinusoidal frequencies (the 
triplet): frequencies ƒ1 
and ƒ2 and modulation 
component at frequency 
ƒ1 + ƒ2 (Rampil, 1998; 
Sigl and Chamoun, 
1994).  For each triplet, 
the bispectrum, 
B(ƒ1,ƒ2), is calculated based on the Fourier transformation (Equation 4) (Rampil, 1998; Sigl and 
Chamoun, 1994).  When computing the bispectrum, the signal is divided into relatively short 
epochs for calculation and then averaged over a number of epochs to provide a stable estimate of 
the true bispectral values (Rampil, 1998).  Therefore, the bispectrum reflects the phase coupling 
between the component sinsuoids as well as the power information (Rampil, 1998; Sigl and 
Chamoun, 1994). 
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At any specific frequency you can have a single sinusoid component or intermodulation 
products resulting from phase coupling.  There is no way for the system to tell them apart from 
one another, but the interest really lies in how much phase coupling is in the signal.  Therefore, 
to quantify the amount of phase 
coupling in the signal, the 
bicoherence is needed.  To 
calculate the bicoherence, you 
first need to calculate the 
maximum amount of phase 
coupling that is possible.  This 
is referred to as the real-triple 
product (RTP) (Equation 5) 
(Sigl and Chamoun, 1994).  The 
bicoherence (BIC) is therefore 
calculated as a ratio of the 
actual amount of phase coupling 
in the system (bispectrum) to 
the square root of the maximum 
amount of phase coupling possible (RTP) (Equation 6) (Sigl and Chamoun, 1994).  The 
bicoherence is presented as a percentage of phase coupling from 0% to 100% (Sigl and 
Chamoun, 1994).   Figure 4 is a representation of the signal transformation from a time domain, 
to frequency domain, to bispectrum analysis of a patient prior to induction of anesthesia.   
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Calculation of the Burst Suppression to be Used in Anesthesia Depth Monitoring 
During levels of deep 
anesthesia, burst suppression 
is seen in the time domain 
signal; an EEG morphology 
that—unlike other features 
of the EEG during 
anesthesia—is not observed 
during natural sleep.  Burst 
suppression is defined as 
periods of high or normal 
voltage alternating to 
periods of time with low or 
isoelectric voltages (Rampil, 1998; Sigl and Chamoun, 1994; Tonner and Bein, 2006).  
Burst suppression is induced by large doses of anesthetic and can be quantified by 
reporting the burst suppression ratio (Figure 5) (Rampil, 1998; Sarkela et al., 2002; Tonner and 
Bein, 2006).  The burst suppression ratio equals the total time of burst suppression divided by the 
epoch length used to analyze the sample (Sarkela et al., 2002).   
Calculation of the Bispectral Index based on EEG Transformation  
The Bispectral Index (BIS) is a complex parameter that is composed of a time domain 
(burst suppression analysis), frequency domain (power spectrum, bispectrum interfrequency 
phase relationships) and high order spectral subparameters and is proprietary in nature 
(Johansen, 2006; Rampil, 1998).  To calculate the BIS, based on the EEG transformation 
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principles discussed earlier, the EEG is filtered to exclude the high and low frequency artifacts of 
the signal (Rampil, 1998).  After the first filter pass, the signal is divided into epochs of 2 
seconds in length (Rampil, 1998).  There are a series of algorithms that the signal is processed 
through with the goal to remove or ignore artifacts (Rampil, 1998).  These algorithms can 
remove ECG or pacemaker spikes from the signal and interpolate the missing EEG data.  These 
epochs can therefore still be used in the processing of BIS.  Eye blinking from the EOG is 
considered noise and is excluded from the analysis.  The remaining epochs are then checked for 
low-frequency electrode noise and if some are 
detected another filtering process is applied to reject 
the low frequencies.  The variance is also calculated 
for each epoch of the EEG (Rampil, 1998).  The 
variance of a specific epoch is investigated by 
looking at the average of the previous recent epochs 
of the raw EEG waveform.  If there is a difference, 
the new epoch will be marked as noisy and discarded 
from the analysis; however, that epoch variance will 
be incorporated into making a new updated average.   
This change in the running average of the epoch 
variances will allow for a slow adaptation to changes 
of new variances.  Once the EEG epoch is artifact 
free or corrected, the degree of burst suppression is 
calculated using the time domain of the epoch.  The 
degree of burst suppression calculation into the BIS 
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is done with two separate algorithms; burst suppression ratio (BSR) as described earlier and 
QUAZI suppression index (detects burst suppression in the presence of wandering baseline 
voltages) (Rampil, 1998).   Next, the waveform data are ready to be converted to the frequency 
domain per the Fast Fourier Transformation processes and the bispectrum is calculated.  The 
actual calculation of the BIS number is a proprietary combination of the EEG subparameters 
already explained.  The BIS value was derived from experimental data on approximately 5,000 
hours of recording on 1,500 anesthetics that varied in the mode and type of drug given (Sigl and 
Chamoun, 1994).  The BIS reports a dimensionless number from 100 (awake) to 0 (isoelectric) 
that decreases continuously with decreasing levels of consciousness and that incorporates the 
power, frequency, beta activation, burst suppression, and bicoherence (Figure 6) (Gelb, 2009; 
Johansen and Sebel, 2000; Rampil, 1998).  The BIS that is presented to the observer is an 
average value that is derived from the previous 60seconds of usable data (Rampil, 1998).     
BIS Placement 
Clinically, the BIS was 
approved by the Food and 
Drug Administration for 
human subjects use in 1996 
and uses a series of four 
electrodes that are placed 
along the forehead of the 
patient according to the 
international 10-20 electrode 
nomenclature placement to monitor two channels of the EEG in a proprietary ipsilateral frontal-
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temporal montage configuration (Figure 7 and Figure 8) (1991; Johansen, 2006; Teplan, 2002; 
Watson et al., 2008).  The four electrodes are placed on different coronal lines of the brain: 
frontoparietal (FPz amd FP1), anterior frontal (AF7) and frontotemporal (FT9) (1991; Johansen, 
2006). The sensor placed on AF7 (lead 4) is the grounding electrode and measures the 
electromyography of the frontalis muscle of the 
forehead (Johansen, 2006).  The electrodes are 
placed in a montage configuration that allows for 
amplification of electrical activity in the brain based 
on a pair of scalp electrodes (Sloan, 2006).  The 
proprietary BIS sensor montage is from lead 1 to 
lead 3 and lead 2 to lead 3 (Figure 7) (Johansen, 
2006).  Each electrode is encased in a small plastic 
sponge that is embedded in a conductive gel to have 
good electrical contact with the patient’s skin.  The 
electrode impedance can be less than 5kohms if the 
skin is prepped via an alcohol wipe prior to 
placement (Glass et al., 1997; Rosow and Manberg, 
2001).  The four electrode configuration allows the monitor to perform an automatic impedance 
check (Rosow and Manberg, 2001). The electrodes are connected to the BIS module via a single 
cable for display to the clinician.   
Anesthetic Effects on the BIS 
The BIS is purported to measure a state of the brain and not the concentration of a 
specific anesthetic drug.  It is therefore necessary to interpret how the BIS value will change 
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depending on the medication type correlated to the sedation level of the patient.  The raw EEG 
component change with a specific anesthetic, therefore the processed EEG in the BIS value also 
reacts differently depending on the anesthetic of choice.   
GA is associated clinically with a decrease in the average EEG frequency and the 
increase in the average power (Rosow and Manberg, 2001).   However, most drugs used in GA 
do not have a simple monotonic relationship to dose response in respect to the cases in EEG 
frequency and power (Rosow and Manberg, 2001).  The Bispectral analysis in the BIS is 
advantageous to this situation since it is using the harmonic and phase relationship (bicoherence) 
of the EEG.   
In 1997, shortly after the approval for patient use, Glass et al. sought to determine the 
sedation levels in relationship to the BIS values and drug concentrations in the blood for four 
commonly used anesthetics and analgesics: propofol, midazolam, isoflurane, and alfentanil in 
healthy volunteers (Glass et al., 1997).  Each patient had a recorded BIS value and level of drug 
concentration in the blood to correspond to the modified observer’s assessment of 
alertness/sedation scale which ranges from 0 (does not respond to noxious stimulus) to 5 
(responds readily to name spoken in normal tone) (Glass et al., 1997).  Glass et al. determined 
that for propofol, the BIS value correlated significantly better to levels of sedation than the blood 
concentration (Glass et al., 1997).   For midazolam and isoflurane, the BIS value was equally as 
effective as the blood concentration levels in predicting levels of sedation (Glass et al., 1997).  
No patients lost consciousness from alfentanil and therefore were excluded from the analysis 
(Glass et al., 1997).  All three subsequent group data were then pooled for BIS values to 
determine the BIS value at which unconsciousness was induced.  50% of patients were 
unconscious at a BIS value of 67 and 95% of patients were unconscious at a BIS value of 50 
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(Glass et al., 1997).  Glass et al. was the first group to prove that BIS may be a valuable tool in 
monitoring sedation and unconsciousness in patients under anesthetics.  It is therefore common 
practice to titrate anesthetics to a BIS value of 40-60 (Glass et al., 1997).   
Since Glass et al. published the first article assessing the utility of the BIS monitor, 
several other investigators have assessed the usability of the BIS monitor in different clinical 
situations using a variety of commonly used anesthetics.  Liu et al. sought to evaluate the 
effectiveness of BIS in determining the level of consciousness for patients under propofol 
sedation for regional anesthesia procedures (Liu et al., 1997).  They determined that BIS was a 
useful tool and showed that both BIS and explicit recall decreased with increasing levels of 
sedation (Liu et al., 1997).  Iselin-Chaves et al. evaluated the BIS value when an anesthetic 
(propofol) plus an opioid (alfentanil) were used in conjunction with one another in healthy 
volunteers (Figure 9) (Iselin-Chaves et al., 1998).  They concluded that BIS correlated well with 
level of sedation even in the presence of an opioid (Iselin-Chaves et al., 1998).  Interestingly, 
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Iselin-Chaves et al. also discovered that BIS responds to painful stimuli by increasing in value 
(Iselin-Chaves et al., 1998).  However, this response can be ablated by giving opioids or 
increasing the propofol concentration to control the pain from the stimuli (Iselin-Chaves et al., 
1998).  Nitrous oxide is a commonly used gas during GA and therefore the use of nitrous oxide 
as it relates to the BIS value was a necessary area of research.  Rampil et al. sought to determine 
the effects on the BIS and 
EEG when healthy young 
adult volunteers where given 
nitrous oxide in five different 
concentrations (Rampil et al., 
1998).  It was determined that 
nitrous oxide does cause an 
increase in the theta and beta 
waves in the EEG, however, 
the BIS values did not change 
and the volunteers remained 
responsive (Figure 10) 
(Rampil et al., 1998).  Barr et al. shared the interpretation that nitrous oxide does not affect the 
BIS values even when the subject is rendered unconscious (Barr et al., 1999).  Puri followed up 
these finding on nitrous oxide and published a case report on two patients who underwent open 
heart surgery with nitrous oxide and isoflurane for anesthesia (Puri, 2001).  The BIS values were 
high when nitrous oxide was used but decreased when the nitrous oxide was stopped and then 
increased again once re-initiated (Puri, 2001).  This suggests that perhaps the use of nitrous oxide 
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in conjunction with other inhaled anesthetics may change the BIS values to a higher value and 
therefore should not be used to guide a clinician’s decision making process to measure adequate 
depth of anesthesia. Sevoflurane, which is another commonly used anesthetic vapor during GA, 
did show a decrease in the BIS value when the subject was rendered unconscious (Figure 11) 
(Barr et al., 1999). 
Although not an anesthetic, the effect of neuromuscular blockade medications on the BIS 
must also be understood.  
Neuromuscular blockade 
agents are commonly used for 
part of or the entire surgical 
case.  Messner et al. sought to 
determine the relationship 
between electromyographic 
activity and the BIS value 
(Messner et al., 2003).  It was 
discovered that fully awake 
volunteers had a substantial 
decrease in BIS (down to 9) 
due to the use of muscle blockade and concluded that BIS may not be a reliable marker for 
assessing sedation in patients where neuromuscular blockade is needed (Messner et al., 2003). 
Around the same time, investigators hypothesized that BIS monitoring could help to 
decrease emergence times from anesthesia since the care provider could titrate the anesthetic to a 
targeted BIS value and ensure the patient did not have excessive anesthesia that would delay 
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emergence.  Gan et al. developed a prospective trial in which all patients received the same 
anesthetic protocol consisting of propofol, alfentanil and nitrous oxide (Gan et al., 1997).  Half 
of the patients received BIS monitoring titrating anesthetics to reach BIS values between 40 and 
60 during the case and half did not.  They found that patients in the BIS monitoring groups 
received less propofol during the case and had significantly faster recovery times than the 
traditional monitoring group (Gan et al., 1997).  This could be a potentially important finding to 
help with the increasing cost in medical care.  However, Yli-Hankala et al. also studied 80 
patients undergoing surgery (Yli-Hankala et al., 1999).  Half of the patients were randomly 
allocated to BIS monitoring and half the patients were monitored per standard of care.  Yli-
Hankala et al. also found that the patients receiving BIS monitoring had a decrease in the use of 
anesthetics (propofol and sevoflurane) and quicker recovery times but concluded the observed 
benefit did not justify the cost of the monitoring system (Yli-Hankala et al., 1999).  Johansen et 
al. analyzed profiles of 1,552 adult patients emerging from GA on and determined that when the 
BIS was targeted and maintained between 50-65,  patients had reduced emergence and recovery 
times (Johansen et al., 2000).  These studies suggest that with BIS monitoring targeted to a 
specific value, the patients may need less anesthetic, emerge from anesthesia quicker and having 
a faster post-anesthesia recovery profile. However, the results of these small efficacy trials have 
not been validated by effectiveness data (Gan et al., 1997; Johansen et al., 2000; Yli-Hankala et 
al., 1999).   
The BIS monitor, along with other EEG-based modules, has limitations.  There are 
several commonly used drugs or devices that can interfere with the BIS function in routine 
clinical care: use of depolarizing muscle relaxant, activation of electromagnetic equipment or 
devices, patient warming systems or planned hypothermia induction (ASA Task Force, 2006).  
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Also, drugs such as ketamine and nitrous oxide have different receptor targets than the more 
commonly used GABAergic drugs and may be associated with erroneous values (Jameson and 
Sloan, 2006).  Rampil et al. determined that although the EEG changes during nitrous oxide 
administration for sedation, the BIS value did not change (Rampil et al., 1998).  The patient’s 
pre-existing co-morbidities may also may confound BIS values.  Patients with Alzheimer’s 
disease, severe hypoglycemia, cerebral ischemia, and neurologic diseases have been shown to 
have lower BIS values (Mashour, 2006; Schnider et al., 1998).  Some unforeseen intraoperative 
events such as cerebral ischemia or hypoperfusion, gas embolism, and unrecognized hemorrhage 
may also produce a rapid change in BIS values even though the anesthetic regimen remained 
unchanged (ASA Task Force, 2006).   
BIS Prospective Clinical Trials 
 The correlation of BIS values with sedation levels has been established in healthy 
volunteers or in closely controlled trials.  However, the utility of the BIS monitor in preventing 
AWR had not been addressed until 2004.  Since that time there have been three large randomized 
trials investigating the utility of BIS when compared to standard of care monitoring in clinical 
practice and targeted end-tidal anesthetic concentrations for high risk surgical patients under 
general anesthesia: the B-Aware trial, the B-Unaware trial, and the BAG-RECALL trial.   
The B-Aware trial assessed whether BIS monitoring decreases the incidence of AWR in 
high risk surgical patients compared to standard of care monitoring techniques (Myles et al., 
2004).  This was a multi-center double-blinded randomized trial in which patients were randomly 
assigned to BIS monitoring or routine care.  All patients received GA per their anesthesia care 
provider and there were no set anesthetic protocols for the study.  All patients received a BIS 
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electrode placed regardless of randomization but only those that were randomized to BIS 
monitoring were actually connected to the BIS monitors for intraoperative monitoring.  For 
patients allocated to the BIS group, anesthesia was adjusted to maintain a targeted BIS value 
between 40 and 60 during the surgical case from laryngoscopy (intubation) to surgical closure.  
BIS was recorded per the anesthesia care provider every 5 minutes for the first hour and every 10 
minutes after the first hour.  All patients were interviewed for AWR post-operatively at 2-6 
hours, 24-36 hours and 30 days.  Any potential AWR patients were further evaluated by a 
committee of three experienced anesthesiologists.  The patients were coded as awareness, 
possible awareness or no awareness.  2,503 patients were enrolled but 40 were excluded due to 
various reasons (Myles et al., 2004).  All patient baseline characteristics were similar between 
the two groups.  At the 30 day post-operative interview, the BIS group (n=2, 0.17%) had a 
significantly lower incidence of AWR than the standard of care group (n=11, 0.91%) (Myles et 
al., 2004).  The combination of possible or definite AWR events showed no statistical difference 
between the groups: 22 in the BIS group (1.8%) and 27 in the standard of care group (2.2%) 
(Myles et al., 2004); however, “possible awareness” cases at that time included patients who 
dreamt under anesthesia, which is no longer thought to be a “near-miss” awareness event 
(Samuelsson et al., 2008).  Myles et al. concluded that their B-Aware trial proved that BIS 
monitoring could reduce the relative risk of awareness by 82% (95% CI 17-98%) in high risk 
general anesthesia surgical patients (Myles et al., 2004).  They also noted that the BIS patients 
did not have a significant difference in the time to recover from GA than patients with normal 
standard of care monitoring.  Although this trial was performed in a routine clinical setting and 
therefore the data are generalizable to the high risk surgical population, it is not generalizable to 
patients at all risk levels of awareness.  Myles et al. therefore suggested the use of BIS 
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monitoring is warranted in patients at high risk of AWR that are undergoing a general anesthetic 
(Myles et al., 2004).      
 The B-Unaware trial assessed whether a BIS-based anesthetic protocol is better than a 
protocol based on the measurement of end-tidal anesthetic concentration (MAC) for decreasing 
AWR in high risk surgical patients undergoing GA (Avidan et al., 2008).  This was a single-
center, prospective study in which consecutively numbered patients were pre-randomized in 
blocks of 50 to BIS monitoring or 50 to MAC based monitoring.  All patients received the BIS 
sensor but for those patients randomized to the MAC group, the clinicians were not able to see 
BIS values.  MAC was visible to both group’s clinicians during the surgical case.  For the BIS 
group, an alert sounded if the BIS exceeded 60 or fell below 40; there were no set MAC alerts.  
For the MAC group, an alert sounded if the concentrations fell below 0.7 MAC or exceeded 1.3 
MAC.  BIS and MAC concentrations were recorded every second and data were downloaded 
into a computer system for analysis.  All patients were interviewed three times (within 24 hours, 
between 24-72 hours, and 30 days after extubation) using the Brice awareness interview.  Any 
patient interview that reported remembering something between “going to sleep” and “waking 
up” via the Brice interview was hand-reviewed by an independent panel to determine if the 
patient had definite awareness, potential awareness, or no awareness.  2000 patients were 
enrolled but only 1941 completed the study due to various reasons; there were 967 in BIS group 
and 974 in MAC group (Avidan et al., 2008).  The patients in the MAC group had a statistically 
significant larger population with underlying neurologic disease than the BIS group (Avidan et 
al., 2008).  Otherwise, the two groups had similar baseline co-morbidities.  The B-Unaware trial 
found that four patients had definite AWR; two in the BIS group and two in the MAC group 
(Avidan et al., 2008).  The overall incidence of definite AWR in this trial is 0.21% (Avidan et al., 
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2008).  Five patients had possible AWR; four in the BIS group and one in the MAC group.  The 
overall incidence of definite or possible AWR in this trial was 0.46% (Avidan et al., 2008).  
Avidan et al. concluded that a structured BIS intraoperative protocol is not superior to a MAC 
based monitoring approach nor did it reduce the administration of volatile anesthetic gases when 
compared to a protocol based on MAC (Avidan et al., 2008).  They noted that the BIS values 
were persistently under 60 during the period of awareness for the majority of the definite and 
possible AWR cases.  Avidan et al. emphasized the point that these data cannot be extrapolated 
to patients under total intravenous anesthesia since all patients received volatile agents for this 
trial; importantly, approximately 43% of patients in the original B-Aware trial received total 
intravenous anesthesia (Avidan et al., 2008).  Avidan et al. concluded that BIS based protocol is 
not superior to MAC based protocol in preventing AWR (Avidan et al., 2008).   
 The BAG-RECALL trial expanded upon the B-Unaware methodology in order to 
determine definitively whether a BIS guided alerting system is superior to a MAC guided 
alerting system in prevention of AWR (Avidan et al., 2011).  The investigators prospectively 
randomized 6,041 adult patients at high risk for AWR across three surgical centers (Avidan et 
al., 2011).  All patients received a BIS monitor but those randomized to the MAC guided alerting 
system, the BIS values were blinded from the anesthesia provider.  For patients randomized to 
the BIS guided alerting system, both the BIS values and MAC values were visible to the 
anesthesia provider.  In the BIS guided group, an audible alarm was generated if the BIS value 
when above 60 or fell below 40.  There were no alarms set for the MAC values in this group.  In 
the MAC guided group, an audible alarm was generated if the MAC fell below 0.7 or exceeded 
1.3 using an age-adjusted formula, since MAC values change with age.  Data were electronically 
captured at a minimum of 1 minute intervals.  Patients were interviewed for awareness within 72 
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hours after surgery and at 30 days after tracheal extubation.  Nine patients were found to have 
definite AWR (0.16% incidence) and 27 patients were found to have definite or possible AWR 
(0.47% incidence) (Avidan et al., 2011).  When investigating the incidence of definite AWR by 
randomization group, seven of the nine patients were allocated to the BIS targeted group (Avidan 
et al., 2011).  Nineteen of the 27 patients who were found to have definite or possible AWR were 
in the BIS targeted group (Avidan et al., 2011).  It was therefore concluded that alerts based on 
BIS values are not superior to MAC-guided alerting system.   
The B-Aware, B-Unaware, and BAG-RECALL all show that those patients randomized 
to BIS monitoring have similar incidence of AWR (approximately 0.2%), which is lower than 
what would be predicted in a high-risk population (approximately 1%).  The studies differ in that 
the B-Unaware and BAG-RECALL trials suggest that a MAC-based protocol may be as 
efficacious as a BIS-based protocol in patients receiving inhaled anesthetics.  However,  the role 
of BIS monitoring in reducing the incidence of anesthesia awareness still needs further 
investigation, specifically as it relates to patients at all levels of risk undergoing anesthesia with 
both intravenous and inhalational agents.   
Decision Support Alerting Systems Driving Provider Actions 
 An advantage of having a processed EEG signal transformed into a numerical index is 
that there is can be a quantitative threshold for decision support alerts to be implemented.  
Decision support alerting is relatively new to the medical community and is based upon the use 
of an automated clinical documentation system that is programmed to alert clinicians to a 
potential adverse event.  These alerts are designed to drive a change in clinical practice by 
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making the provider aware of the potential for an adverse event based upon set threshold criteria 
for which going above or below could increase risk of patient harm.   
Kucher et al. were one of the first investigative teams to use an electronic alert system to 
alter an adverse event: venous thromboembolism in hospitalized patients (Kucher et al., 2005).  
They hypothesized that electronic alerts sent to the provider would increase the rate at which 
patients were administered prophylaxis against deep-vein thrombosis (DVT).  The hospital 
electronic database was queried in real time for patients at risk of DVT and determined if the 
patient was on adequate prophylactic measures.  For those patients that did not have adequate 
prophylactic measures in place, they were randomly allocated to the clinician receiving an 
electronic alert about DVT prophylactic measures or no alert sent to the treating clinician.  
Kucher et al. found that the electronic alert reduced the risk of DVT or pulmonary embolism at 
90 days by 41% (Kucher et al., 2005).  This served as a proof of concept that a simple 
programming technique could impact the adverse event rate of patients. 
O’Reilly et al. were among the first investigators to use an anesthesia information system 
(AIMS) to improve timely administration of prophylactic antibiotics (O'Reilly et al., 2006).  
AIMS is an electronic record of all perioperative documentation and monitoring.  These systems 
can be as simple as having an automated history and physical section or as advanced as having 
an intraoperative system that captures electronically all physiological variables, all medications, 
and all surgical events.  O’Reilly et al. saw a need for timely administration of prophylactic 
antibiotics to decrease surgical site infections (O'Reilly et al., 2006).  This was accomplished by 
programming the AIMS to remind the anesthesiologist to administer the antibiotics within one 
hour of the surgical incision.  The program tracks the time of surgical incision and therefore 
could remind the clinician when one hour had lapsed without an input of antibiotic 
 
38 
 
administration into the system.  If the antibiotic was not administered the anesthesiologist was 
prompted to answer why.  The study was designed so clinician feedback was available and 
compliance rates were posted around the operating rooms.  Those with poor compliance were 
specifically targeted by team members.  A manual chart review prior to implementation of the 
AIMS showed a 69% compliance rate (O'Reilly et al., 2006).  After one year, the compliance rate 
increased to 92% (O'Reilly et al., 2006).  This study supported the concept that a simple 
programming change can affect patient care and decrease adverse events. 
Kheterpal et al. the following year at the same institution used the AIMS to improve 
compliance for documentation of arterial line placement (Kheterpal et al., 2007).  Documentation 
of arterial line placement is important to professional fee reimbursement as well as to the need 
for completeness of the medical record.  Once again the AIMS was programmed into two 
groups; the experimental group received alpha-numeric text messages and emails for up to 2 
days after a stated operation to document the arterial line and the control group received no text 
messages or emails.  The AIMS could determine if an arterial line was placed for the patient and 
used during the surgical operation and could also determine if a professional note used for fee 
reimbursement was drafted into the system.  If the patient had the arterial line but not the 
professional note for fee reimbursement the case was considered non-compliant.  Prior to the 
study commencement, there was an 80% compliance rate for documentation.  After the 
complication of the study, the experimental group showed a 93% compliance rate compared to 
an 84% compliance rate in the control group (p<0.001) (Kheterpal et al., 2007).  Due to the 
statistical increase in compliance, the department decided to implement the system for all 
patients, which increased the departmental compliance to 99% and showed a profit of $151,000 
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in professional fee charges (Kheterpal et al., 2007).  This study proves that alert systems are 
beneficial.   
The use of AIMS is now widely adapted across the country which lends itself to 
developing and implementing new research technologies that use provider entered point-of-care 
comorbidity information on a specific patient into the system and then integrate a risk profile 
with the actual dynamic physiologic changes that occur during an operation to alert the clinician 
to potential adverse outcomes.  The research that has been previous completed using AIMS, has 
proved the utility in the framework that the use of an AIMS can drive changes in provider care 
and hopefully minimize adverse outcomes in surgical patients.  Such technology therefore has 
the potential to minimize complications such as intraoperative awareness.  
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Research Hypothesis:  Anesthesia Information System alerting based on a novel anesthetic 
concentration algorithm (incorporating the use of intravenous anesthetics) or an EEG-
guided algorithm will reduce the known incidence of intraoperative awareness 
Specific Aim 1: Development of an age-adjusted minimum alveolar concentration (MAC) 
alerting protocol within an Anesthesia Information System incorporating the inhalational vapor 
MAC with common intravenous anesthetic infusions that may have been given to the patient. 
Rationale: MAC is the current standard of care in monitoring anesthetic depth of patients while 
under general anesthesia.  The age-adjusted MAC value measures the actual partial pressure of 
the inhaled anesthetic vapor in the alveoli of the lungs which is the partial pressure of the 
anesthetic vapor in the brain.  Therefore MAC is not directly related to the neuroanatomic 
substrate of consciousness, the brain (Mashour, 2006).  In addition, the MAC does not 
incorporate intravenous anesthetic use. Therefore, to adequately alert clinicians in the prevention 
of awareness, a “MAC Equivalent” is developed that uses the actual age-adjusted MAC and 
incorporates the use of two commonly used intravenous anesthetic agents. 
Specific Aim 2:  Conduct a prospective randomized comparative effectiveness trial to determine 
if either the anesthetic concentration alerting protocol (using the MAC equivalent alerting 
algorithm) or a BIS alerting protocol is superior in the prevention of definite intraoperative 
awareness in an unselected adult surgical population.   
Rationale:  To date, there have been no comparative effective trials investigating the use of 
anesthetic concentration monitoring and BIS monitoring in the prevention of intraoperative 
awareness.  The previous trials were performed on patients classified at high-risk for 
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intraoperative awareness (Avidan et al., 2011; Avidan et al., 2008; Myles et al., 2004) and used 
only inhalational MAC monitoring compared with BIS monitoring.   
Specific Aim 3: Identification of a specific population-based threshold using both age-adjusted 
MAC and BIS for the prevention of intraoperative awareness using discrete continuous 
anesthesia information system monitoring data. 
Rationale:   The protocols for MAC and BIS monitoring that have been previously used were not 
determined using prospectively collected discrete data elements in the prevention of 
intraoperative awareness.  Therefore, using the unselected adult surgical population and the 
discrete monitoring data electronically extracted from the anesthesia information system, a 
specific threshold can be determined that maximizes sensitivity and specificity in the prevention 
of intraoperative awareness.    
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Chapter 2: Bioinstrumentation and Data Acquisition/Extraction System 
 The University of Michigan Health System uses the Centricity® (General Electric (GE) 
Healthcare®) Anesthesia Information System (AIMS) and AISYS Anesthesia Machines® (GE 
Healthcare®).  Physiologic variables (heart rate, blood pressure, BIS values) are displayed on the 
GE Marquette Solar 9500® monitor (GE Healthcare®).   Anesthetic monitoring variables are 
displayed on the AISYS display monitor (GE Healthcare®).  All BIS electrodes (Aspect 
Medical®) were placed while the patient was awake in the pre-operative holding area.  Upon 
entry into the operating room, the electrodes were connected via a single cable to the BIS tram 
module (Aspect Medical®).  The tram module interfaced with the GE Marquette Solar 9500® 
monitor (GE Healthcare®).  A complete picture of the anesthesia monitoring set-up can be found 
in Figure 1.   
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 The physiologic variables displayed on the GE Marquette Solar 9500® monitor and the 
anesthetic variables from the AISYS Anesthesia Machines® are transmitted electronically every 
30 seconds to one of many servers to be saved into databases over GE Unity Network (GE 
Healthcare ®).  A unity network interface device (ID) (GE Healthcare ®) is used as a 
communication bridge between the different devices. The Unity Network ID (GE Healthcare ®) 
connects the different devices via a device identification communication adapter (DIDCA) 
automatically (Figure 2 and 3). 
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For this specific research, depth of anesthesia was monitored 
using the BIS.  The BIS module tram (Aspect Medical®) is 
inserted into the tram rack and connected to the GE 
Marquette Solar 9500® monitor (Figure 4).  The BIS values 
are transmitted over the Unity Network the same as the 
other physiologic variables displayed on the GE Marquette 
Solar 9500® monitor.   
 
 The AIMS system (Centricity Perioperative Anesthesia (CPA) (GE Healthcare®)) is 
installed and runs on a personal computer (PC) within each operating room.  The AIMS CPA can 
also be installed and run on any PC that is logged into the firewalled hospital network.  The 
AIMS CPA features a pre-operative history and physical, an intraoperative management, and a 
post-operative recovery room section.  The pre-operative history and physical is completed by 
the anesthesia care provider prior to the operation.  Information is entered at the point-of-care 
using co-morbidity specific pull-down menus.  Every selection has a discrete code that is stored 
within the Centricity Clinical Data Repository (CDR) database (GE Healthcare®).  In addition, 
the provider has an option to hand-type in any additional information as warranted. These 
selections can then be retrospectively queried and coded to be used for research.  The 
demographic and laboratory data are automatically fed into the CDR and displayed on the AIMS 
CPA using interfaces with the hospital information system.   
The AIMS CPA intraoperative section provides three distinct features of intraoperative 
care management.  First, there is an anesthetic script that is a pre-selected guideline of events 
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expected to occur during the case.  The script elements can be selected via a touchscreen in the 
operating room which is then transmitted into the database with a specific date and time stamp.  
Due to the nature of the operating room, the provider can adjust the time of a selection if there 
was not the opportunity to document the event in 
real-time.  Each specific script element is also stored 
with a discrete value and can be queried 
retrospectively.  The script elements define important 
parts of the operation such as anesthesia start and 
end, type of intubation (if any), and the type of 
anesthetic used along with the time the doses were 
administered (Figure 5).   Second, the precise values 
of the physiologic variables from both the monitor 
and the anesthesia machine are displayed in table 
format.  This allows the clinician to review the 
intraoperative record and determine if the patient 
received a general anesthetic via inhalational of 
intravenous agents (Figure 6 and 7).  Finally, the physiologic waveforms from the monitor are 
also displayed on the AIMS CPA screen.   
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The transformation of monitor-capture to visualization on the AIMS CPA requires 
numerous data transmission and data truncating steps (Figure 8, steps A-G described below).  
The entire data acquisition system is running behind a firewalled password-protected system 
within the University of Michigan Health System, which is monitored and regulated by the 
Clinical Application Systems (CAS) team within the Department of Anesthesiology.  The 
monitors from the AISYS Anesthesia Machines® and GE Marquette Solar 9500® monitor (A) 
are receiving information from the various physiologic variables being collected during the 
operation.  The physiologic variables that are collected can either be continuous or discrete.  For 
example, heart rate is collected each time the patient’s heart beats while a blood pressure taken 
with a blood pressure cuff may only be taken every 3 to 5 minutes.  The data from the monitors 
(A) is then transmitted via the GE Unity Network (which is the monitor capture interface) to one 
of many servers that is running GE’s monitor capture software (GE Healthcare®) (B).  Each 
server running the monitor capture software has two Ethernet connections.  The first is a unity 
network connection that is able to pull physiologic variables from the GE Marquette Solar 
9500® monitor and the AISYS anesthesia machine and transmit those data to the hospital 
network.  The second Ethernet connection transmits data from the hospital network to the 
hospital server.  This monitor capture software (B) uses the IP address from each operating room 
monitor and every 30 seconds pulls data from the monitors that is being transmitted over the 
unity network.  The data are inserted into a local database (C).  Both the monitor capture 
interface and the local database (B and C) reside on the same server.  The 30-second data pulled 
from the monitors via the monitor capture interface is then transmitted to a hospital level central 
database (D) via a DataLink interface.  The hospital level central database (D) holds the data 
collected every 30-second off the unity network.  Data are continuously being pulled and placed 
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into the hospital level central database regardless of whether an operation is occurring.  Due to 
the massive amount of discrete data points, this centralized hospital database is purged once a 
week.  The CAS team has developed a structured query language (SQL) (E) to extract data from 
the centralized hospital database (D) into the Centricity CDR database (F).  The data are 
extracted from the centralized hospital database (D) into the Centricity CDR (F) for an actual 
operation.  Instead of the more granular 30-second data pull, this SQL code asks for data to be 
pulled into Centricity CDR every 60 seconds.  In addition, the data are also aggregated into 15-
minute snap-shots that are represented graphically in the intraoperative record in a table format 
for the clinician to review in the AIMS CPA (Figures 6 and 7).  As previously stated, the AIMS 
CPA application is running (G) on a standard PC in the operating room at the patient’s bed side.  
The AIMS CPA application (G) samples the Centricity CDR (F) for data every minute to update 
the screen on the AIMS CPA application (G) that is visible to the clinicians.  The clinicians’ 
hand-entered information into the AIMS CPA application (G) in real-time such as script 
elements for start and end of operation or medications administered, is transmitted back to the 
CDR database (F).  There are continuous data transmissions between the CDR and AIMS CPA 
application until the case has been ended by the clinician within the AIMS CPA application.  The 
CDR database (F) now holds continuously collected data at a rate of every 60-seconds, all 
individual data entries (e.g., blood pressure by cuff) and any user entered information at the 
point-of-care in the operating room into the AIMS CPA application such as script elements or 
medications.  All data transmitted to the CDR database (F) are kept indefinitely and considered 
the patient’s medical record.   
For research purposes the CDR database (F) can be queried using SQL.  The SQL query 
is extracted and entered in any statistical package for analysis at a later time.  Each SQL query is 
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developed by the investigative team but written and executed by the CAS programmers.  Since 
all preoperative history and physical elements are stored as discrete variables, the investigator 
can identify a specific co-morbidity of interest and code the data into binary (yes/no) or 
categorical concepts for analysis.  Continuous intraoperative physiologic variables can be 
extracted either minute to minute as they are captured, a median over a set time-point, or a 
high/low value during the operative case.  All intraoperative data can be queried or alerts can be 
generated by set anesthesia script elements that are time-stamped.  For the research presented in 
this dissertation, the script elements of “anesthesia induction end” to “surgical dressing end” 
were used as the timestamps to capture all depth of anesthesia monitoring variables and to 
determine when to alert the clinician.  These script elements were used to document the exact 
time that anesthesia was induced for the specific patient, who should thereafter be adequately 
anesthetized; to the time that anesthesia would be reversed or turned off.  In addition, to 
determine any monitor capture interface issues with data transmission into the CDR database, 
queries were developed to determine if standard measures from the anesthesia machine were 
invalid.  If the CPA application had a documented start and end of the surgical case time-
stamped but the anesthetic depth value for MAC and the end-tidal carbon dioxide were both 
zero, those cases were classified as monitor capture interface issues.   
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Chapter 3 – Development of a Novel Electronic Algorithm for Detecting 
Potentially Insufficient Anesthesia: Implications for the Prevention of 
Intraoperative Awareness 
With growing recognition of the problem of intraoperative awareness (AWR), there is a 
strong impetus to develop effective methods of detecting insufficient levels of anesthesia.  
Assessment of anesthetic depth has evolved from stages and planes of anesthesia, to the concept 
of minimum alveolar concentration (MAC), to more recent techniques based on 
electroencephalography (EEG) (Mashour, 2006).  There is still controversy, however, regarding 
the efficacy of EEG-based technology in the prevention of awareness.  The B-Aware trial was a 
prospective study of high-risk patients that demonstrated a benefit of Bispectral Index (BIS) 
monitoring compared to a routine care group (Myles et al., 2004).  One limitation of this trial 
was that the BIS-guided approach was not compared to another protocol-based anesthetic.  The 
recent B-Unaware trial was a prospective study that instead compared a BIS-guided anesthetic to 
a protocol based on >0.7 MAC end-tidal anesthetic gas concentrations (Avidan et al., 2008).  The 
B-Unaware study did not demonstrate any benefit of a BIS-guided protocol compared to a MAC-
guided protocol.  One limitation of the B-Unaware trial was that it was restricted to inhalational 
agents.  Since the BIS monitor is sensitive to the effects of intravenous anesthetics, a protocol 
that incorporates the MAC-sparing effects of such agents may be a better comparator to the 
EEG-based approach. 
Methods 
We developed an electronic algorithm that employs our anesthesia information 
management system to calculate a "MAC equivalent" based on total inhalational MAC, as well 
as documented infusions or boluses of intravenous agents.  The algorithm for analysis of an 
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active case is as follows, with an associated electronic pager alert triggered if implemented in 
real time. 
• Conditions for an “active case” are: 
1. data capture is possible (i.e., not a paper record) 
2. data capture is active (i.e., “patient in room” has been electronically 
entered and end-tidal [Et] CO2 is detected) 
3. case has been identified as a general anesthetic 
4. “anesthesia induction end” has already been documented  
5. request for recovery room bed or transport to an intensive care unit has not 
been documented 
6. surgical dressing completion has not been documented 
• The alerting system checks the most recent value (within a specified time period) of:  
1. Et Sevoflurane (MAC=2.0) 
2. Et Isoflurane (MAC=1.2) 
3. Et Desflurane (MAC=6) 
4. Et Nitrous Oxide (MAC=105) 
and compares it to the MAC of each agent.  It adds the resulting MAC values   together 
for “current total MAC.”   
• The system then checks for a charted propofol infusion in mcg/kg/min and divides by 
150, assuming that 150 mcg/kg/min is “1.0 MAC” for propofol.  The analogous concept 
of MAC for propofol is “Cp50”- the plasma or blood concentrations at which 50% of 
patients do not move in response to a noxious stimulus (Smith et al., 1994).  Since we do 
not have the technology at our institution to calculate Cp50 or Cp50-awake, we have 
chosen the above propofol dose as an initial value based on clinical experience.  The 
resultant MAC equivalent is added to current total MAC. 
• The system next checks for a dexmedetomidine infusion with a rate of 0.2 mcg/kg/hour 
or greater.  If present, it multiplies the current total inhalational MAC by 2, as 
dexmedetomidine can reduce MAC by 50% (Aantaa et al., 1997).  
• At this point, the “current total MAC” is defined as: Et Sevo /2 + Et Iso /1.2 + Et Des/6 + 
Et Nitrous /105 + propofol rate (in mcg/kg/min)/150.  If dexmedetomidine is >0.2 
mcg/kg/hour, inhalational MAC is multiplied by 2. 
• If this total MAC is below a set threshold, the system assesses whether a bolus of 
propofol, midazolam, etomidate, or thiopental has been documented in the preceding 10 
minutes. 
• The system then triggers an alert if total age-adjusted MAC is below the assigned 
threshold AND no bolus has been documented in the preceding 10 minutes.  Age 
adjustment for MAC is only performed for volatile agents and is based on calculations 
derived from prior literature (Eger, 2001; Nickalls and Mapleson, 2003) (Table 1).  
• If implemented, the clinician electronically signed into the case receives an alphanumeric 
page stating “Potentially insufficient anesthesia, please check vaporizers and intravenous 
lines.” 
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Table 1: Age-adjustment ranges for minimum alveolar concentration (MAC).  
Age (years) 1 MAC (%) 
Des:    18-39  7.0 
           40-59 6.0 
           60-79 5.2 
           80-99 4.5 
Sevo:  18-39  2.4 
           40-59 1.7 
           60-79 1.5 
           80-99 1.2 
Iso:     18-39  1.3 
           40-59 1.1 
           60-79 1 
           80-99 0.8 
Des= Desflurane, Sevo= Sevoflurane, Iso= Isoflurane 
After Institutional Review Board approval (HUM 4487, University of Michigan Health 
System), we retrospectively applied the algorithm to the electronic intraoperative data of adult 
general anesthesia cases at our University Hospital from 2/07 through 1/08 in which no 
awareness was reported.  In order to assess a differential frequency of alerting, we 
retrospectively analyzed electronically documented cases of AWR that occurred from 1/04 
through 1/08 using the same age-adjusted MAC thresholds.  AWR were identified through 
routine postoperative interviews assessing any problems related to anesthesia, rather than an 
explicit query such as the Brice interview.  Age, gender, body mass index (BMI), American 
Society of Anesthesiologists (ASA) classification status, use of total intravenous anesthesia, 
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emergent cases, and cardiac cases were assessed and compared between the two groups 
(awareness vs. no awareness). Comparisons were made using Chi-Square, Fischer’s Exact Test, 
or Mann Whitney U Test, where appropriate.  P values <0.05 were considered statistically 
significant. 
The B-Unaware trial used 0.7 MAC as a threshold; we started above this value and 
decreased thresholds until they approached MAC awake (Eger, 2001).  The threshold for 
analysis was set to <0.8, <0.7, <0.6, <0.5, <0.4 age-adjusted MAC.  After calculating the 
incidence of alert triggering in cases with or without awareness, positive and negative likelihood 
ratios were calculated. 
Results 
From 2/07 through 1/08, we identified 15,091 cases valid for analysis that had no 
documented AWR.  From 1/04 through 1/08, we identified 12 cases of AWR for which 
electronic data were available (9 of these are discussed and documented in Mashour et al, 2009).  
Demographic data from the two groups are demonstrated in Table 2.  The only significant 
difference between the two groups was an increased incidence of ASA 3, 4, and 5 patients in the 
awareness group (75%) compared to the non-awareness group (40%) (P=0.02).  
In all cases analyzed, the incidence of triggers decreased as MAC thresholds were 
decreased (Table 3).  The AWR, however, demonstrated a higher frequency of alert triggers at 
all MAC thresholds.  The <0.8 age-adjusted MAC threshold was most sensitive to AWR and had 
the best negative likelihood ratio, since it triggered in 12/12 cases.  The threshold of <0.5 age-
adjusted MAC was associated with the best positive likelihood ratio.   
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Table 2: Demographic data for the study population.   
 -Awareness  
n=15,091 
+Awareness  
n=12 
P value 
Age 52.2 ± 16.6 60.3 ± 15.3 0.10 
Male Gender 47.7% (7,192) 58.3% (7) 0.46 
BMI 28.8 ± 7.1 29.1 ± 8.4 0.94 
ASA 3,4 or 5 39.9% (6,015) 75% (9) 0.02 
TIVA 1.7% (259) 0% (0) 1.00 
Emergent 6.9% (1,041) 8.3% (1) 0.58 
Cardiac  1.8% (279) 0% (0) 1.00 
P values were calculated either using Chi-Square, Fischer’s Exact Test, or Mann Whitney U 
Test. BMI= Body mass index, ASA= American Society of Anesthesiologists classification, 
TIVA= Total intravenous anesthesia 
Table 3: Assessment of trigger frequency in a retrospective study of 15,091 patients without 
awareness and 12 patients with awareness.   
Trigger 
Thresholds 
% Trigger  
 -Awareness 
n=15,091 
% Trigger 
+Awareness  
n=12 
Positive Likelihood 
Ratio 
Negative 
Likelihood Ratio 
<0.8 aa-MAC 85.3% 100% 1.17 0 
<0.7 aa-MAC 78.7% 91.7% 1.17 0.39 
<0.6 aa-MAC 69.2% 91.7% 1.33 0.27 
<0.5 aa-MAC 57.8% 83.3% 1.44 0.4 
<0.4 aa-MAC 48.9% 66.7% 1.36 0.65 
Minimum alveolar concentration (MAC) thresholds were age-adjusted (aa) and incorporated the 
infusion of the intravenous agents propofol and dexmedetomidine 
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Discussion 
Electronic alerts have been developed and employed at our institution and have been 
shown to increase compliance with both clinical and administrative tasks (Kheterpal et al., 2007; 
O'Reilly et al., 2006).  To our knowledge, this is the first report of an electronic algorithm and 
alert system designed to detect potentially insufficient anesthesia.  Empirically-derived 
refinement of both the algorithm and alert threshold will help further determine the optimal 
“signal-to-noise” ratio (i.e., tradeoff between sensitivity and specificity) for detecting insufficient 
anesthesia related to true intraoperative awareness events.  It is important to note that the present 
findings are consistent with clinically relevant investigations in AWR.  Our alert system would 
have triggered in 78.7% of cases with a threshold of <0.7 effective MAC, which is comparable to 
the 74.5% incidence of end-tidal gas concentrations <0.7 MAC in the B-Unaware study (Avidan 
et al., 2008).  
One advantage of the system is its ease of installation and cost efficiency: assuming that 
an anesthesia information management system is in place, the algorithm can be employed 
readily.  A second advantage is that a more comprehensive assessment of anesthetic agents can 
be accomplished, in contrast to the limited MAC calculation available on many monitors.  MAC-
sparing infusions or boluses are common and should be accounted for in a MAC-based protocol.  
A third advantage is that the algorithm can be readily modified and could potentially include data 
from EEG-based monitors as well.  
One disadvantage of the algorithm is that it only incorporates intravenous infusions or 
boluses that have been electronically documented.  In general, poor documentation could lead to 
under- or over-alerting.  For example, a mechanical malfunction of an intravenous line that 
resulted in no anesthetic delivery would not be detected if not charted, as there is no direct 
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information from the patient as in the case of end-tidal gas concentrations.  Another disadvantage 
is that in our protocol, the MAC equivalent for propofol is established by convention rather than 
a physiologic measure such as Cp50 (Smith et al., 1994).  In the future, both of these 
disadvantages may be compensated for if the use of end-tidal propofol concentrations becomes a 
standard of practice (Takita et al., 2007).  Furthermore, we cannot attest to the complete absence 
of awareness cases in the control group, as a prospective approach to awareness detection was 
not used (Mashour et al., 2009c).  Nonetheless, even assuming the reported incidence of 
awareness cases at 0.15% in the control group, it would likely not affect the outcome given the 
awareness incidence of 100% in the test group.  Finally, this algorithm obviously requires an 
anesthesia information management system and alphanumeric paging system already in place. 
The exclusion of opiates from our algorithm merits discussion.  It is well known that, 
beyond a certain dosing threshold, opiates have a MAC-sparing effect.  A combination of 
premedication, intermittent boluses, and continuous infusions—often with different agents—is 
common in the perioperative setting. Incorporating this heterogeneous practice would add 
considerable complexity to the algorithm in this initial phase of development.  It is important to 
note that cases traditionally conducted with high-dose opiates, such as cardiac surgery, are still 
associated with a high incidence of intraoperative awareness (Avidan et al., 2008; Myles et al., 
2004).  It is also important to note that current practice does not typically include even a simple 
MAC alarm (Umesh et al., 2009).  Thus, the development of an automated, modifiable alerting 
system that can be programmed at different thresholds of age-adjusted MAC—and that is 
inclusive of selected intravenous sedative-hypnotic agents—is already a major advance 
compared to existing technology.  A large clinical trial testing the algorithm in comparison to the 
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BIS monitor is currently being conducted (clinical trial NCT00689091), which will help 
elucidate empirically whether opiates need to be included in the next iteration of the algorithm.   
In conclusion, we have developed a novel electronic algorithm and alerting system that 
may help detect insufficient anesthesia and that is more sensitive to cases of intraoperative 
awareness.  The prospective study of such an electronic alert system may be useful as a standard 
of comparison for EEG-based systems and warrants further investigation as an adjunct in the 
prevention of awareness during general anesthesia.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted in entirety from Springer: Journal of Clinical Monitoring and Computing (23) 2009: 
273-277, A Novel Electronic Algorithm for Detecting Potentially Insufficient Anesthesia: 
Implications for the Prevention of Intraoperative Awareness, Mashour G.A., Esaki, R.K., 
Vandervest, J.C., Shanks A., Kheterpal, S. Entire text with tables with kind permission from 
Springer Science and Business Media 
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Chapter 4 – Prevention of Intraoperative Awareness with Explicit Recall in an 
Unselected Surgical Population: A Randomized Comparative Effectiveness 
Trial  
Intraoperative awareness with explicit recall  (AWR) of surgical events is a potentially 
devastating event associated with post-traumatic stress disorder (Leslie et al., 2010) and has an 
incidence of approximately 0.15% for all risk levels (Sandin et al., 2000; Sebel et al., 2004).  
Processed electroencephalographic monitors have been developed to assess anesthetic depth and 
potentially prevent AWR, which is considered a sentinel event by the Joint Commission 
(JACHO, 2004).  The Bispectral Index® (BIS) monitor (Covidien, Boulder, CO) processes a 
frontal electroencephalographic channel to calculate a dimensionless number from 100 (awake) 
to 0 (no detectable brain activity) in order to provide a measure of the patient's level of 
consciousness; a BIS range of 40 to 60 is suggested to be consistent with the state of general 
anesthesia (Avidan et al., 2011; Avidan et al., 2008; Myles et al., 2004).  
Past efficacy trials have evaluated the role of protocols based on the BIS monitor (Avidan 
et al., 2011; Avidan et al., 2008; Myles et al., 2004) and anesthetic concentrations (Avidan et al., 
2011; Avidan et al., 2008) for the prevention of AWR.  However, these studies were performed 
exclusively in patients at high risk for the complication. A large cohort study did find that BIS 
monitoring decreased the incidence of AWR in a broad surgical population compared with 
historical controls, but was limited by its observational design, changing practice patterns 
regarding end-tidal anesthetic concentration monitoring, and exclusion of patients not receiving 
neuromuscular blockers (Ekman et al., 2004).  As such, there are currently no comparative 
effectiveness data to guide the decisions of providers or policy makers as they attempt to prevent 
AWR in the >200 million major surgeries performed worldwide each year (Weiser et al., 2008).  
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Similarly, there are no effectiveness data supporting the claim that anesthetic 
consumption is reduced with the use of a BIS monitor, which has been suggested to decrease 
inhaled anesthetic use by up to 38% (Song et al., 1997).  These data are reinforced by meta-
analyses of small efficacy trials of both inhaled and intravenous anesthesia (Liu, 2004; 
Punjasawadwong et al., 2007).   It has recently been argued that decreased anesthetic use and the 
ensuing clinical benefits such as faster recovery or reduced nausea and vomiting make the BIS 
monitor cost-effective and that it should therefore be routinely incorporated (Klopman and Sebel, 
2011).  
Here we describe a comparative effectiveness study with active comparators and a two-
sided superiority design.  This randomized controlled trial compared alerting protocols based on 
either anesthetic concentration or BIS values in an unselected surgical population at three 
hospitals within a tertiary academic medical center.  The primary outcome was the incidence of 
definite AWR; prespecified secondary outcomes included the incidence of definite or possible 
AWR, as well as anesthetic usage and recovery variables.  
Materials and Methods  
A detailed description of the experimental protocol for the Michigan Awareness Control Study 
(ClinicalTrials.gov number NCT00689091) has been previously reported (Mashour et al., 
2009b). The conduct of the study and the reporting of results followed the Consolidated 
Standards of Reporting Trials guidelines (Schulz et al., 2010).  
Participants 
The study received approval from the Institutional Review Board of the University of 
Michigan, Ann Arbor, (HUM00013626) and was deemed to be of minimal risk. A full discussion 
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of the risks and benefits was conducted with each patient approached. Patient consent to 
interventions and follow-up was electronically documented in our perioperative information 
system (Centricity®, General Electric Healthcare, Waukesha, WI). Patients were recruited from 
three hospitals of the University of Michigan Health System from May 2008 until May 2010. 
Inclusion criteria were age >18 years, general anesthesia using inhalational or intravenous 
technique for any surgical case that did not involve the forehead, and availability for follow-up 
interviews. Exclusion criteria were intracranial procedures, adhesive allergy, psychosis, or 
history of traumatic brain injury. All patients enrolled in the study were blinded to group 
assignment and had the BIS electrode applied to the left side of the forehead by a member of the 
research staff prior to entering the operating room. 
To detect a reduction in the incidence of AWR from 0.15% to 0.04% (Ekman et al., 
2004), we calculated a need for 14,072 per group or a total n = 28,144 with 80% power and a 
significance level of 5%. We targeted a total recruitment of 30,000 patients, with a pre-specified 
interim analysis after 20,000 patients were recruited (2/3 target sample) (Mashour et al., 2009b).   
A constant likelihood group sequential method with formal futility boundaries was used with a 
two-sided O’Brien-Fleming stopping rule. There was no contingency for early termination for 
efficacy. An acceptance region plot (or a futility region plot) was generated using SAS statistical 
software (SAS version 9.2, Carey, NC). The two-sided futility boundary (for the differences in 
proportions between the BIS and the anesthetic concentration group) at the planned interim 
analysis was from -0.0005434 to 0.0005434. The difference between the proportions observed at 
the interim analysis was 0.0003275422 (11/9376 cases of definite awareness in the anesthetic 
concentration group minus 8/9460 cases of definite awareness in the BIS group), which is within 
the stopping boundary for futility. 
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Study Design 
The University of Michigan Health System utilizes the Centricity® electronic 
perioperative information system in all of its operating rooms. Using this system, automated real-
time analysis of BIS values or minimum alveolar concentration (MAC) was performed every 
five minutes, with the transmission of provider-specific electronic alphanumeric paging alerts in 
less than 60 seconds. Operating rooms were randomized every three months based on even- or 
odd-numbered operating rooms to either (1) electronic alerts in the event of median BIS values 
>60, or (2) electronic alerts for median age-adjusted MAC level of <0.5.  The threshold of age-
adjusted MAC <0.5 was chosen based on a retrospective analysis of electronically documented 
cases with and without awareness that occurred prior to the onset of the study (Mashour et al., 
2009a),  as well as the high frequency with which thresholds of higher MAC are crossed (Avidan 
et al., 2008).   In addition to the age-adjusted MAC of standard inhaled anesthetics, alerting 
based on anesthetic concentrations also reflected documented intravenous anesthetic infusions 
and bolus doses (Mashour et al., 2009a).   Paging alerts to the clinician electronically signed into 
and physically present during the case reported either the median BIS value or anesthetic 
concentration level for the prior 5 min epoch, followed by "Potentially insufficient anesthesia- 
please check vaporizers and intravenous lines." (Specific coding for the electronic alerts can be 
found in Appendix I.) 
In the BIS-targeted rooms, BIS values appeared on the main monitoring screen and were 
automatically recorded. In the anesthetic alert-targeted rooms, BIS values neither appeared on 
the monitor nor were accessible intraoperatively. Other aspects of anesthetic care (e.g., choice of 
anesthetic agents, benzodiazepines) were not standardized for this study.   
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Randomization and Blinding 
Randomization was performed using a random-number, computer-generated block 
scheme based on even or odd operating room number. The blocks were defined within a specific 
year of the study based on the original start date of recruitment.  The study year was divided into 
four quarters by calendar month (three months per quarter).  Within a specific study year, the 
odd-numbered operating rooms and even-numbered operating rooms were randomized to BIS 
alerting two times and anesthetic concentration alerting two times.  If the odd-numbered 
operating rooms were randomized to one alerting protocol, the even-numbered operating rooms 
were randomized to the alternative alerting protocol for that quarter of the study year.  Patients, 
postoperative interviewers, and all case reviewers were blinded to group assignment. 
Practitioners receiving pages regarding BIS or MAC values were not blinded to group 
assignment.  However, practitioners were not made aware of the randomization scheme or dates 
for randomization change during the study.  
Technical Factors 
The BIS monitors used in the Michigan awareness control study were not free-standing 
devices, but modules that interfaced with the Solar 9500 (General Electric®) anesthetic monitors 
used in our institution’s operating rooms. During scheduled quality control checks within the 
first two months of the trial, it became clear that in some instances there was a failure of BIS 
values to be generated. Technical representatives from both manufacturers confirmed this as a 
known software interface problem. Since the study was designed as an effectiveness trial, the 
decision was made to proceed and use the population receiving neither the BIS nor anesthetic 
concentration protocol as a post hoc “no intervention” group for the purpose of secondary 
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analysis.  Failure to generate BIS values was similar in both even (17%) and odd (19%) 
numbered operating rooms, which was the randomization scheme for alerting protocols.   
Main Outcome Measures 
Blinded, trained interviewers used the modified Brice interview (Brice et al., 1970) 
employed in other studies of intraoperative awareness (Avidan et al., 2011; Avidan et al., 2008; 
Myles et al., 2004; Sebel et al., 2004) to screen patients 28 to 30 days after surgery via telephone.  
A single interview was performed in contrast to past trials (Avidan et al., 2011; Avidan et al., 
2008; Myles et al., 2004) due to the high number of patients recruited; the 28 to 30 day interview 
was chosen because it would likely detect the most clinically significant awareness events. If 
patients could not be reached by telephone after multiple attempts, a written form of the 
interview was sent to the patient. Any patients reporting AWR during the Brice interview had a 
more detailed interview by an anesthesiologist committee member blinded to the intervention. 
All patients reporting AWR were offered psychiatric care.   
For those patients who reported AWR, three blinded experts independently determined 
whether the reported event was definite, possible, or no awareness based on the data obtained 
from the first two interviews (Brice screening and follow-up). These individuals also reviewed 
awareness events for the BAG-RECALL trial (ClinicalTrials.gov number NCT00682825) 
(Avidan et al., 2011; Avidan et al., 2009).  We compared inter-rater agreement using Fleiss’s 
Kappa statistic for the three blinded assessments of awareness, which showed fair agreement 
(0.25). In the event of a conflict, a fourth blinded expert reviewer from another institution made 
the final determination; this expert reviews cases for the American Society of Anesthesiologists 
Anesthesia Awareness Registry. The qualitative aspects of the awareness report were classified 
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using the Michigan Awareness Classification Instrument (Mashour et al., 2010).  Class 1 is 
defined as isolated auditory perceptions, class 2 is tactile perceptions, class 3 is pain, class 4 is 
paralysis and class 5 is paralysis and pain.  If an event is also associated with distress, the class 
number is modified with a “D.”   
Anesthetic usage, time to meeting recovery room discharge criteria, and incidence of 
postoperative nausea/vomiting were prespecified secondary outcomes (Mashour et al., 2009b).  
Postanesthesia care unit discharge criteria include (among other variables): oxygen saturation 
>92% or preoperative baseline (at appropriate levels of supplemental oxygen), core temperature 
between 36⁰ and 38⁰ Celsius, normal heart rate and rhythm (or no worse than baseline status), 
other hemodynamic vital signs within normal physiologic range for age or within 20% of 
baseline values, normal neurological evaluation, pain score ≤4, postoperative nausea and 
vomiting ≤2.  BIS values, MAC values, and doses of propofol, midazolam, fentanyl and 
morphine were assessed across all groups. 
Statistical Analysis 
The primary outcome was the incidence of definite AWR in the anesthetic concentration 
and BIS groups using modified intention-to-treat analysis.  Modified intention-to-treat was 
defined as a patient who was randomized and was interviewed at 30 days. Prespecified 
secondary analysis was conducted to determine the combined incidence of definite and possible 
AWR as well as the classification of events. Significance was assessed using a two-tailed 
Pearson chi-square test. Confidence intervals were calculated using Newcombe’s method 
without continuity correction (Newcombe, 1998).   The average number of paging alerts 
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generated in the groups was compared with the incidence of definite or possible AWR events 
using a linear regression R-Squared test.  
Patient characteristics, comorbidities, and risk factors for awareness (Table 1) were 
analyzed to determine if there were statistically significant differences between the anesthetic 
concentration and BIS groups in the modified intention-to-treat analysis.  The Kolmogorov-
Smirnov statistic was used to determine normality for the two continuous variables (age and 
body mass index).  If the p-value was significant (<0.05), the assumption of normality was 
violated and nonparametric analyses (e.g., Mann-Whitney U test) were used.  Nonparametric 
data are presented as median and interquartile range [25th to 75th percentile].  Parametric data are 
presented as mean ± standard deviation.  For categorical variables, a two-tailed Pearson chi-
square test was used, where a p-value of <0.05 was considered statistically significant.  All 
categorical data are presented as number (percentage). For ease of interpretation we have defined 
cardiovascular disease as having one or more of the following conditions: history of myocardial 
infarction, congestive heart failure, valvular heart disease, dysrhythmia, endocarditis, peripheral 
vascular occlusive disease, angina or orthopnea.  We have defined lung disease as having one or 
more of the following conditions: history of pulmonary hypertension, chronic obstructive 
pulmonary disease or dyspnea.  We have defined liver disease as having one or more of the 
following conditions: history of cirrhosis, acute liver failure, or chronic liver failure.  We have 
defined neuropsychiatric disease as having one or more of the following conditions: history of 
stroke or transient ischemic attack, seizures, depression, bipolar disorder, anxiety disorder, or 
posttraumatic stress disorder.  We have defined alcohol abuse as having 3 or more drinks daily 
and/or high withdrawal potential.   
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For the other key secondary outcomes, all continuous elements were assessed for 
normality as described.  We chose to use the post hoc grouping variable (anesthetic 
concentration, BIS, and no intervention) to assess the secondary outcomes and therefore post hoc 
comparison testing was employed for elements in Table 2.  The median BIS values were 
compared between the BIS and anesthetic concentration groups using a Mann-Whitney U test; a 
Kruskal-Wallis test was used to compare median anesthetic dosages and discharge times among 
the anesthetic concentration, BIS, and no intervention groups. A two-tailed Pearson chi-square 
test was used to compare the outcomes of nausea or vomiting among the three groups. 
Bonferroni adjustments were used for the Mann-Whitney U test variables.  For the variables that 
were analyzed using the Kruskal-Wallis test, pair-wise comparisons using a series of Mann-
Whitney U tests were performed if the omnibus test was significant.  For the Bonferroni 
adjustment, we started at an alpha level of 0.05.  Based on the number of comparisons required, 
the new alpha level to measure significance was 0.002.  We calculated a total of 22 comparisons 
based on the number of embedded Mann-Whitney U tests that were performed for Kruskal-
Wallis tests with significant omnibus tests. Only those pairwise comparisons with a p-value 
<0.002 were reported in Table 2 as statistically significant differences.  If there were no 
statistically significant pairwise comparisons, “NS” (no significance) was reported for ease of 
interpretation.  Statistical software IBM SPSS statistics version 19 (IBM Corp, Somers, NY) was 
used. 
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Results 
Recruitment and patient characteristics 
A total of 21,601 patients were enrolled in the study at the time of interim analysis, with a 
97% recruitment rate (Figure 1). As described in the methods, the study was terminated due to 
futility. Of the study cohort, 18,836 or 87% of the patients were available for postoperative 
interview assessing awareness at one month; 9460 patients were randomized to the BIS group 
and 9376 patients were randomized to the anesthetic concentration group (Figure 1).  Patient 
characteristics and comorbidities for the modified intention-to-treat BIS and anesthetic 
concentration groups are demonstrated in Table 1. There were no adverse events related to the 
study. 
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Figure 1: Flow diagram of recruitment and follow-up interviews. BIS=Bispectral Index 
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Table 1:  Patient characteristics, comorbidities, and risk factors for awareness 
 
  
Anesthetic 
concentration 
n (%) 
(N=9,376) 
 
Bispectral 
Index 
n (%) 
(N=9,460) 
 
p-value 
Male Sex 4,199 (45) 4,237 (45) 0.99 
Age in years* 53 [41 to 64] 53 [41 to 64] 0.79 
Body Mass Index (kg/m2)* 28 [25 to 33] 28 [24 to 33] 0.50 
Cardiovascular Disease 1,702 (18) 1,723 (18) 0.91 
Lung Disease 950 (10) 967 (10) 0.84 
Renal Disease 601 (6.4) 612 (6.5) 0.87 
Liver Disease 88 (0.9) 58 (0.6) 0.01 
Neuropsychiatric Disease 2,003 (21) 2,053 (22) 0.57 
History of Awareness 50 (0.5) 59 (0.6) 0.41 
History of Difficult Intubation 45 (0.5) 40 (0.4) 0.56 
Narcotic Dependency 9 (0.1) 11 (0.1) 0.67 
Alcohol Abuse 205 (2.2) 180 (1.9) 0.17 
Current Anti-Convulsant Therapy 222 (2.4) 202 (2.1) 0.28 
Current Benzodiazepine, Barbiturates, or GABA agonist 3,490 (37) 3,438 (36) 0.21 
 
*Non-parametric data presented as median [25th to 75th percentile interquartile] range.   
All categorical data elements are presented as number (%) 
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Of the 9460 patients randomized to the BIS intervention and successfully interviewed, 
3384 or 36% did not have BIS data recorded due to technical issues described in Materials and 
Methods (Technical Factors). This population was used for secondary analysis only as a post hoc 
control group because it had neither intervention; there were more females (p<0.001) and more 
patients with lung disease (p=0.002) in this group. Neither female sex nor lung disease were 
shown to be associated with an increased incidence of intraoperative awareness in our recent 
companion randomized controlled trial (Avidan et al., 2011).   
Incidence of intraoperative awareness events 
The overall incidence of definite awareness in the study cohort was 19/18,836 or 0.1%. 
By modified intention-to-treat 
analysis, the incidence of definite 
AWR was 11/9376 or 0.12% (95% 
CI 0.07 to 0.21%) in the group 
randomized to the anesthetic 
concentration protocol and 8/9460 
or 0.08% (95% CI 0.04 to 0.16%) in 
the group that was randomized to receive BIS monitoring (p=0.48, Figure 2).  
Using the Michigan Awareness Classification Instrument, no statistical differences in 
event or distress classes were found between the groups. Post hoc power analysis revealed that 
102,951 patients in each group would be required to detect a difference between the two 
interventions.  The 13% of recruited patients who did not complete interviews (e.g., due to death 
or lack of response) were unlikely to skew the reported incidence of AWR. Assuming the same 
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incidence rates found in the modified intention-to-treat groups, 100,000 simulations were run to 
generate cumulative distribution functions that demonstrate the probability of a significant 
difference of outcome if the 2765 patients not interviewed were included.  Using a Fisher’s exact 
test, the likelihood of a significant difference with inclusion of this population was 0.016%. 
By post hoc analysis, the incidence of definite AWR was 11/9376 or 0.12% in the 
anesthetic concentration group, 3/6076 or 0.05% in the group that actually received BIS 
monitoring, and 5/3384 or 0.15% in the no intervention group (p=0.27). Based on the 0.12% 
awareness incidence in the anesthetic concentration group and the 0.05% awareness incidence in 
the group that received BIS monitoring, a post hoc power analysis revealed that 29,996 patients 
in each group would be required to 
detect a difference between the two 
interventions. The combined 
incidence of definite and possible 
AWR cases was 0.08% in the group 
that received BIS monitoring, 
0.20% in the anesthetic 
concentration group and 0.38% in 
the no intervention group (p=0.006, Figure 3). By post hoc analysis, the cohort receiving no 
intervention had 4.7 times more definite or possible awareness events compared to the cohort 
receiving the BIS protocol  (p=0.001; 95% CI 1.7 to 13.1). Of patients with definite or possible 
awareness receiving BIS monitoring, 50% had no 5-min epoch of BIS values <60 during the case 
and 50% had at least one 5-min epoch of median BIS value >60.      
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By secondary analysis using post hoc grouping, the average number of alerts in the no 
intervention group (0/case), anesthetic concentration group (1/case), and BIS group (2.2/case) 
varied inversely with the incidence of definite and possible awareness events (r2=0.951). 
BIS Values, Anesthetic Usage, and Recovery 
The secondary outcome measures of anesthetic use and recovery times were performed 
using the post hoc comparison groups of anesthetic concentration, BIS, and no intervention.   
Since the decision was made to present the data using the three post hoc groups instead of the 
modified intention-to-treat grouping (BIS or anesthetic concentration), Bonferroni adjustments 
were performed as described in the Statistical Analysis section of the Materials and Methods.  
Data are presented in Table 2, with only significant pair-wise comparisons reported.  There was a 
statistically significant difference in the median MAC for pairwise comparisons of anesthetic 
concentration to no intervention groups and also for BIS to no intervention groups. Intraoperative 
propofol bolus dosing showed a significant pair-wise comparison between the BIS and no 
intervention groups.  The total midazolam dose showed no statistically significant differences.  
Total fentanyl and total morphine use had statistically significant pair-wise comparisons for all 
combinations of the three grouping variables. Although statistically significant, the clinical 
relevance of these differences is unclear.   
Median time to meeting recovery room discharge criteria was 98 min (interquartile range 
66 to 140) for anesthetic concentration group, 95 min (interquartile range 64 to 138) for the BIS 
group, and 94 min (interquartile range 64 to 133) for the no intervention group. There was a 
significant pair-wise comparison between the no intervention and anesthetic concentration 
groups.  There was no evidence for reduced recovery time in patients receiving BIS monitoring 
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compared to no intervention.  There was no statistically significant difference among the three 
groups for reduced nausea or reduced vomiting upon first assessment in the recovery room 
(Table 2).  
Table 2:  Anesthetic use and recovery variables 
 Anesthetic 
concentration 
(N=9,376) 
Bispectral 
Index 
(N=6,076) 
 
No intervention 
(N=3,384) 
 
p-value 
BIS Values* 
% complete data (n) 
40 [34 to 46] 
41% (3,885) 
40 [35 to 44] 
100% (6,076) 
N/A 
N/A 
NS 
MAC Values** 
%complete data (n) 
0.9 [0.8 to 1.1] 
98% (9,170) 
0.9 [0.8 to 1.1] 
99% (5,988) 
0.9 [0.8 to 1.1] 
98% (3,303) 
<0.001 (Pairwise-
comparisons of No 
Intervention to 
Anesthetic 
Concentration 
AND No 
intervention to 
BIS) 
Propofol 
Intraoperative 
Bolus (mg)** 
% complete data (n) 
170 [130 to 200] 
 
 
100% (9,376) 
180 [130 to 200] 
 
100% (6,076) 
170 [120 to 200] 
 
100% (3,384) 
<0.001 (Pair-wise 
comparison of No 
intervention to 
BIS) 
Midazolam (mg)** 
% complete data (n) 
2 [2 to 4] 
100% (9,376) 
2 [2 to 4] 
100% (6,076) 
2 [2 to 4] 
100% (3,384) 
NS 
Fentanyl (µg)** 
% complete data (n) 
175 [100 to 250] 
100% (9,376) 
200 [100 to 250] 
100% (6,076) 
150 [100 to 250] 
100% (3,384) 
<0.001 (All 
pairwise 
comparisons) 
Morphine (mg)** 
% complete data (n) 
0 [0 to 5] 
>99.9% (9,374) 
0 [0 to 5] 
>99.9% (6,074) 
0 [0 to 3] 
>99.9% (3,383) 
<0.001 (All 
pairwise 
comparisons) 
PACU Discharge 
Readiness (min)** 
% complete data (n) 
98 [66 to 140] 
 
91% (8,527) 
95 [64 to 138] 
 
91% (5,521) 
94 [64 to 133] 
 
90% (3,043) 
0.001 (Pairwise 
comparison No 
intervention to 
anesthetic 
concentration) 
No Nausea (% of 
patients) (n)*** 
% complete data (n) 
92% (6,184) 
 
72% (6,787) 
93% (4,042) 
 
72% (4,403) 
93% (2,286) 
 
74% (2,506) 
NS 
No Vomiting (% of 
patients) (n) *** 
% complete data (n) 
99% (7,149) 
 
78% (7,329) 
99% (4,617) 
 
77% (4,707) 
99% (2,608) 
 
79% (2,687) 
NS 
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Note: Bonferroni adjustments were made due to post hoc comparisons (α=0.002).  All data using 
the Kruskal-Wallis test also had pair-wise comparisons using a series of Mann-Whitney U tests if 
the omnibus test was significant.  Only p-values < 0.002 in the pairwise comparisons were 
reported as statistically significant differences for these post hoc tests.  
  
*Non-parametric data presented as median [25th to 75th percentile interquartile] ranges and 
evaluated using Mann-Whitney U test .**Non-parametric data presented as median [25th to 75th 
percentile interquartile] ranges and evaluated using Kruskal-Wallis test.  ***Categorical data 
evaluated using Pearson chi-square. 
 
BIS=Bispectral Index, MAC=minimum alveolar concentration, TIVA=total intravenous 
anesthesia, PACU=postanesthesia care unit.  
 
Discussion 
This is the largest prospective randomized controlled trial ever conducted on the 
prevention of AWR and the only such effectiveness trial. This negative study was unable to 
determine if an alerting protocol based on BIS values or anesthetic concentration was superior in 
preventing definite intraoperative awareness.  Other conclusions of the study are that (1) 
comparative effectiveness trials with definitive results regarding the prevention of AWR in 
unselected patients will likely not be feasible, (2) post hoc secondary analysis suggests that a 
protocol based on the BIS monitor probably reduces awareness events compared to routine care 
without a protocol, (3) increased provider alerting is a possible mechanism for decreasing 
awareness events when comparing two protocols, (4) the BIS monitoring protocol used in this 
trial is not associated with a reduction in the use of anesthetic drugs in routine clinical practice, 
and (5) the BIS monitoring protocol used in this trial is not associated with reduced recovery 
time or incidence of nausea and vomiting in routine clinical practice.  
The B-Aware study demonstrated that a BIS-guided protocol significantly reduced the 
incidence of AWR in a high-risk population compared to no intervention (Myles et al., 2004).   
Subsequently, the B-Unaware study demonstrated no difference between a BIS-guided and 
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MAC-guided protocol in the high-risk population (Avidan et al., 2008), a finding supported by 
the recent BAG-RECALL trial (Avidan et al., 2011).   The current study differs from all past 
trials in that it assessed AWR prevention in an unselected, representative surgical population as 
opposed to the high-risk population alone. The primary results of our study are consistent with 
the B-Unaware and BAG-RECALL trials in that no statistically significant difference in the 
prevention of AWR could be demonstrated between anesthetic concentration and BIS monitoring 
protocols.  However, the results of the post hoc secondary analysis are consistent with the B-
Aware trial (Myles et al., 2004) in that the BIS monitor showed a trend toward reducing the 
incidence of awareness events compared to a group with no intervention. One methodological 
similarity of the current trial, the B-Aware trial (Myles et al., 2004) and the observational study 
by Ekman et al., 2004 is that anesthetic administration was not restricted to potent inhaled agents 
alone, as it was in the B-Unaware and BAG-RECALL trials (Avidan et al., 2011; Avidan et al., 
2008).   Our study supports the conclusion of a recent Cochrane database review suggesting that 
the BIS monitor may reduce AWR when compared to assessing clinical signs alone, but not 
when compared to a protocol based on anesthetic concentration (Punjasawadwong et al., 2007).  
The use of the BIS monitor in the current study generated approximately twice as many 
alerts as that of the anesthetic concentration protocol. Therefore, increased alerting could 
potentially be a mechanism of decreased definite or possible AWR events, an interpretation 
supported by the results of our companion trial.  In the BAG-RECALL study, the alarm 
frequency based on anesthetic concentration was approximately 2-fold higher than that based on 
BIS values; the higher alarm rate with the anesthetic concentration protocol was associated with 
fewer definite and possible AWR events.  The different alerting threshold in BAG-RECALL 
(0.7MAC) and the current trial (0.5MAC) likely explains the ostensibly disparate outcomes.  It is 
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important to note that there was a high incidence of false positive alerting, which mitigates any 
conclusion regarding alerting protocols as a method of preventing AWR.  
Efficacy trials and meta-analyses have suggested that the BIS monitor can significantly 
reduce consumption of anesthetic drugs, which leads to improved outcomes such as faster 
recovery or reduced nausea and vomiting. These data have been used to argue that the BIS 
monitor is cost-effective and should be routinely adopted for every general anesthetic (Klopman 
and Sebel, 2011).  The BIS protocol used in the current study was not shown to reduce anesthetic 
dosing, which is in contrast to the recent Cochrane database review (Punjasawadwong et al., 
2007).  Furthermore, the BIS protocol used in the current study was not associated with reduced 
recovery time or reduced incidence of nausea and vomiting compared to routine care. One 
hypothesis to explain the discrepancy is that conclusions derived from efficacy trials or meta-
analyses based on such trials are not sufficiently robust to hold in a test of effectiveness.  
Another hypothesis to explain the discrepancy is that the difference in BIS-guided protocols 
between the current and past studies led to disparate outcomes. 
Limitations of our study include insufficient numbers to answer with precision whether 
and to what extent there is a difference in the definite AWR incidence between protocols based 
on BIS values and anesthetic concentrations.  This limitation likely reflects the rarity of AWR in 
an unselected surgical population and is informative regarding the future investigation of 
protocols to reduce AWR. Another limitation of the trial was the proportion of patients 
randomized to the BIS protocol who did not receive BIS monitoring. However, this unplanned 
technical issue has yielded useful secondary findings and is mitigated by the following 
considerations: (1) even complete compliance would almost certainly not have been sufficient to 
detect a significant difference in the modified intention-to-treat groups, (2) the population 
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receiving neither intervention yielded useful information regarding the effect of anesthetic 
protocols compared to routine care, a matter of recent controversy,(Crosby, 2011) (3) the 
incidence of definite and possible AWR events in the no-intervention group was equivalent to 
that previously reported (Punjasawadwong et al., 2007; Sandin et al., 2000; Sebel et al., 2004),  
which validates the methodology of the trial and suggests that a single interview at 30 days was 
sufficient to detect clinically relevant AWR, and (4) the number of prospectively-studied patients 
who received BIS monitoring nonetheless exceeds all major efficacy trials combined (Avidan et 
al., 2011; Avidan et al., 2008; Myles et al., 2004).  
In conclusion, this effectiveness study could not detect a difference between BIS and 
anesthetic concentration protocols in reducing the incidence of definite AWR with explicit recall.  
By post hoc analysis, we demonstrated that the BIS monitor may play a role in reducing AWR 
compared to no intervention.  These findings are consistent with conclusions of a Cochrane 
review based on various efficacy studies (Punjasawadwong et al., 2007).   In contrast to the 
Cochrane review, the BIS protocol used in this study was not associated with improved recovery.  
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Chapter 5 – Systematic Review for Alerting Thresholds for the Prevention of 
Intraoperative Awareness with Explicit Recall 
Intraoperative awareness with explicit recall (AWR) of surgical events can be a 
devastating complication for patients, with significant psychological sequalae (Domino et al., 
1999; Ghoneim et al., 2009; Leslie et al., 2010; Moerman et al., 1993; Osterman et al., 2001; 
Schwender et al., 1998).   The incidence of definite AWR in patients undergoing general 
anesthesia is reported to be between 1 and 2 out of 1,000 cases and as high as 3 to 4 of 1,000 
cases for both possible and definite AWR events (Mashour et al., 2012; Sandin et al., 2000; 
Sebel et al., 2004); in patients at high risk for AWR, the incidence approaches 1% (Myles et al., 
2004).   It has been posited that the primary reason for AWR is insufficient anesthesia (Ghoneim 
et al., 2009; Nickalls and Mahajan, 2010), suggesting that alerting protocols could prevent AWR 
if a specific threshold was identified.   
Two common surrogates for anaesthetic depth are minimum alveolar concentration 
(MAC) measured by end-tidal anesthetic concentration (ETAC), and the Bispectral Index® 
(BIS).  Alerting algorithms based on either MAC or BIS values can be implemented easily to 
notify the provider of potentially insufficient anesthesia.  The rapid expansion of electronic 
Anesthesia Information Systems (AIMS) allows for enhanced use of alerting algorithms with the 
potential to combine demographic, co-morbidity, physiologic and anesthetic concentration 
variables.  In addition, the AIMS allow the provider to be notified via pager for potentially 
insufficient anesthesia even when the alarms on the primary monitoring system have been 
silenced.   
Clinical trials investigating the prevention of AWR (Avidan et al., 2008; Mashour et al., 
2012; Myles et al., 2004; Zhang et al., 2011) used specific thresholds for potentially insufficient 
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anesthesia, with the provider either being instructed to keep the BIS value between 40 and 60 or 
with audible alarms if the BIS or MAC values fell outside defined ranges.  The MAC and BIS 
values chosen were based on previously published work, but to date, there has been no 
systematic study of the appropriate threshold for MAC or BIS alarms for the prevention of AWR 
based on prospectively collected data.   
The parent trial for this study (Mashour et al., 2012) investigated whether the use of 
alerting algorithms in cases randomized to either anaesthetic concentration or BIS values 
decreased the incidence of AWR.  It did not investigate the discrete MAC or BIS data elements 
to determine whether there is a specific value that would maximize the sensitivity and specificity 
in the prevention of AWR or explore any changes in provider behaviour when alerts are 
generated. Therefore, the objective of this study was to test the hypothesis that there is an 
evidence-based alerting threshold for MAC or BIS values that would maximize the sensitivity 
and specificity of alarms aimed at preventing AWR.  In addition, we sought to determine if 
alerting the provider changes behaviour with respect to anaesthetic management in the 
prevention of AWR.   
Materials and Methods 
 This study is a pre-specified secondary analysis of the Michigan Awareness Control 
Study (MACS) (ClinicalTrials.gov No. NCT00689091) (Mashour et al., 2012).  The parent trial 
and this secondary analysis were approved by the Institutional Review Board (IRB HUM 13626, 
initial study approval 8/14/2007) of the University of Michigan, 2800 Plymouth Road, Building 
520 Room 3214, Ann Arbor, MI 48109 (Chairmen: Drs Michael Geisser and John Weg).  In 
brief, we screened all adult patients between May 2008 and May 2010 presenting to a 
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multihospital healthcare system for surgery in which general anaesthesia using inhaled or 
intravenous anaesthetic.   A detailed discussion with each patient took place and verbal informed 
consent was obtained and documented in our AIMS.  Patients were excluded if the use of a BIS 
monitor was impractical (e.g. intracranial procedures, adhesive allergy, surgery involving the 
forehead) or underlying brain disorder rendered the BIS a questionable measure of consciousness 
(e.g., history of traumatic brain injury).  The BIS Quatro sensor (Covidien, Boulder, Colorado, 
USA) was attached preoperatively in all patients by a member of the research staff.  Alerts to 
notify the provider of potentially insufficient anaesthetic dosing were based on either the age-
adjusted MAC (aaMAC) (Nickalls and Mapleson, 2003) or BIS values.  For the parent trial, 
aaMAC was calculated based on pre-specified age groups (Mashour et al., 2009a).  
A detailed description of the randomisation and blinding is explained elsewhere 
(Mashour et al., 2012; Mashour et al., 2009b) and is briefly summarized here.  The study was 
divided into eight quarters (eight 3-month periods over 2 years), with MAC and BIS alerting 
algorithms randomly assigned for each quarter.  For the MAC alerting rooms, the real-time BIS 
values were hidden from the provider’s view.  In addition, if the median ETAC for a 5-min 
epoch was less than 0.5 aaMAC, an alphanumeric paging alert was sent to the provider in the 
room.  For the BIS alerting group, the BIS values were visible to the provider.  In addition, if the 
median BIS value for a 5-min epoch was greater than 60, an alphanumeric paging alert was 
generated.   A study team member contacted each patient and administered the modified Brice 
interview 28-30 days after surgery (Abouleish and Taylor, 1976; Brice et al., 1970).   As 
described previously, after the modified Brice interview and additional interviews of potential 
AWR patients (Mashour et al., 2012) were performed, each event was categorized as no AWR, 
possible AWR or definite AWR.   Data from other trials in which the authors were involved 
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(Avidan et al., 2011; Avidan et al., 2008) could not be included due to differences in data 
acquisition systems and incomplete records of alarm delivery.    
 For the MACS trial, Centricity® (GE Healthcare, Madison, Wisconsin, USA) was the 
AIMS system used for programming alerts and notifying providers via alphanumeric text paging.  
Centricity® interfaces with the haemodynamic monitors (GE Marquette Solar 9500, Milwaukee, 
Wisconsin, USA) and also with the anaesthesia machine (AISYS Anesthesia Machine, GE 
Healthcare).  ETAC values were automatically calculated in real time from the expired volatile 
anaesthetic concentrations that were collected by the AISYS anaesthesia machine and 
transmitted to Centricity®.  BIS and ETAC data elements were electronically captured for every 
patient by the AIMS every 60s and were available for later study extraction and analysis.   
 For this secondary analysis, we included cases in which inhaled volatile agents were used 
as the primary anaesthetic.   We excluded total intravenous anaesthetic (TIVA) cases, any case 
for which a propofol infusion was used in conjunction with a volatile anaesthetic and any case 
with missing volatile anaesthetic data due to infrequent AIMS data interface issues.   
Secondary Analysis Methodology 
 All cases were reviewed to ensure complete data for ETAC and BIS values from an 
electronically documented time of “anesthesia induction end” to the time of “request for 
postanaesthesia care unit (PACU) bed” or “transport to the ICU.”  For this secondary analysis, 
aaMAC was calculated on the basis of the age documented in the AIMS at the time of operation 
and not on the pre-specified age groups as in the parent trial (Nickalls and Mapleson, 2003).   
The surgery was divided into 5-min epochs (during the AIMS timestamps listed previously) and 
the median ETAC was calculated for each of those 5-min epochs.  The overall median ETAC 
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was also calculated for each case.  The same technique was used for patients with valid BIS 
monitoring data.   
Data were analyzed two different ways to determine a single threshold for the prevention 
of AWR for ETAC and BIS values.  First, the data were dichotomised by whether any 5-min 
epoch was below (aaMAC) or above (BIS) a set value throughout the case.  The maximum 
sensitivity, specificity and Youden’s Index were calculated.  Second, the median ETAC and BIS 
values for the case were analysed using a receiver operating characteristic curve c-statistic.  If the 
c-statistic demonstrated adequate discriminating capacity (> 0.70), then the value with the 
maximum sensitivity and specificity would be computed and retrospectively applied to the 
database to determine a single threshold for the prevention of AWR.   
To investigate whether the alerting algorithm changes provider behaviour, we first 
calculated the percentage of the case during which the anaesthetic concentrations triggered the 
alarm.   This percentage was calculated by dividing the number of 5-min epochs that met the 
ETAC alerting threshold by the number of 5-min epochs overall.  We chose to present the data as 
the percentage of the case duration instead of total minutes of the case to account for the variance 
in length of procedures.  A control group that had no real-time alerting interventions, distinct 
from the ETAC and BIS groups, was used to explore whether there is a behavioural effect by 
retrospectively applying the ETAC alerting algorithm.  This group received neither BIS nor 
MAC alerts yet was still assessed for AWR; the anaesthetic was delivered on the basis of routine 
clinical and hemodynamic variables.  The control group resulted from technical interface issues 
from the parent trial and was not prespecified (Mashour et al., 2012).   However, as there was a 
“no intervention” group that resulted from MACS, we could assess whether there was a 
behavioural effect attributable to having alerts generated throughout the case.  This was 
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accomplished by retrospectively applying the ETAC alerting algorithm to the “no intervention” 
group and calculating what percentage of time the case would have triggered an alarm if an 
algorithm had been active in real time.  The percentage of the case during which the anaesthetic 
triggered the ETAC alerting algorithm was then compared between the original ETAC 
intervention arm and post hoc control group.   The mean percentage of the case that triggered an 
alarm was also examined for change in behaviour across the study period for both the ETAC and 
BIS arms.  If the mean percentage changed across the quarters, this would indicate that 
anesthetic delivery behaviour had changed.   
Statistical Analysis 
 Due to the low incidence of definite AWR in the parent trial and the potential 
psychological impact of possible AWR, we combined definite and possible AWR events into one 
category for this secondary analysis.  To determine whether there was a single threshold that 
maximises sensitivity and specificity for the prevention of AWR, aaMAC for all cases was 
dichotomised by whether the case did or did not have any 5-min median epochs in which the  
aaMAC was less than 0.4, less than 0.5, less than 0.6, less than 0.7, less than 0.8 or less than 0.9.  
The same dichotomising technique was used for cases with valid BIS data that had at least one 5-
min median epoch with BIS more than 60, more than 70, BIS more than 80 or more 90.  The 
baseline BIS threshold was set at 60 because this generally represents the threshold between 
general anesthesia (<60) and sedation or wakefulness (>60) (Glass et al., 1997).  Sensitivity, 
specificity and Youden’s Index were then calculated to determine whether there was an optimal 
threshold for the prevention of AWR for either aaMAC or BIS.  The Youden’s Index was 
calculated as (sensitivity + specificity – 1) (Bewick et al., 2004).  A Youden’s Index of 1 would 
indicate the threshold is perfect and a Youden’s index of 0 would indicate the threshold has no 
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diagnostic value in the prevention of AWR (Bewick et al., 2004). Next, a c-statistic was 
calculated from a receiver operating characteristic curve to determine whether there is a single 
diagnostic threshold for either ETAC or BIS that can be quantified for prevention of AWR.  If 
the c-statistic was deemed adequate (>0.70), then the continuous data for both aaMAC and BIS 
would be analysed to determine the specific threshold in the prevention of AWR.   
 A Mann-Whitney U test was performed to assess whether providers receiving the original 
MAC alerts differed statistically when compared to the “no intervention” (i.e. no alert) group for 
the entire time period and by quarter of the study.   To determine whether there was a 
behavioural change, as documented by a significant difference in the percentage of the case that 
triggered an alert for potentially insufficient anaesthesia, a Kruskal-Wallis test was performed for 
both MAC and BIS arms across the study period.   Data are displayed as the mean percentage of 
the case to trigger an alert ± 2x SEM. 
SPSS® version 20 (IBM® Corp, Armonk, New York, USA) was used for all analyses.  
Data extraction from AIMS was completed using structured query language.  A p-value of less 
than 0.05 was considered statistically significant throughout.   
Results 
 The parent trial had a total of 18,836 patients with complete information on the AWR 
outcome.  We excluded 231 cases because of the use of TIVA, 297 for agent analyser device 
technical issues and 2,240 for use of an adjunct intraoperative propofol infusion.  This resulted in 
the dataset of 16,068 patients, with a total of 32 definite or possible AWR events (Figure 1).   
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Figure 1:  Flow Diagram from Parent Study to Secondary Analysis 
 
Youden’s Index did not demonstrate a single threshold for aaMAC or BIS values in the 
prevention of AWR (Table 1).  The c-statistic for median aaMAC was 0.431 ± 0.046 and 0.491 ± 
0.056 for BIS, indicating that there is not a specific threshold that can be calculated for the 
prevention of AWR when using either aaMAC or BIS values. There were 10 patients who 
experienced an AWR event with BIS values <60 (median for 5-min epoch) for the entire case. 
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Table 1: Sensitivity, Specificity, and Youden’s Index for each case that had valid 
measurements for End-tidal Anesthetic Concentration and Bispectral Index values 
aaMAC 
 Sensitivity (95% CI) Specificity (95% CI) Youden’s Index 
aaMAC <0.4 0.28 (0.14-0.47) 0.79 (0.79-0.79) 0.07 (-0.06 – 0.26) 
aaMAC <0.5 0.38 (0.22-0.56) 0.71 (0.71-0.71) 0.08 (-0.08-0.27) 
aaMAC <0.6 0.44 (0.27-0.62) 0.59 (0.59-0.60) 0.03 (-0.14-0.24) 
aaMAC<0.7 0.59 (0.41-0.76) 0.45 (0.45-0.45) 0.05 (-0.14-0.21) 
aaMAC<0.8 0.78 (0.60-0.90) 0.30 (0.30-0.30) 0.08 (-0.10-0.20) 
aaMAC<0.9 0.81 (0.63-0.92) 0.18 (0.18-0.18) -0.01 (-0.19-0.10) 
 
BIS 
 Sensitivity (95% CI) Specificity (95% CI) Youden’s Index 
BIS ≥ 60 0.09 (0.01-0.43) 0.72 (0.72-0.72) -0.19(-0.28-0.15) 
BIS ≥ 70 0.00 (0.00-0.32) 0.91 (0.91-0.91) -0.09 (-0.09-0.24) 
BIS ≥ 80 0.00 (0.00-0.32) 0.97 (0.97-0.97) -0.03 (-0.03-0.29) 
BIS ≥ 90 0.00 (0.00-0.31) 0.99 (0.99-0.99) -0.01 (-0.01-0.31) 
aaMAC = age-adjusted MAC; BIS = Bispectral Index; CI = Confidence Interval 
 
 When applying the ETAC alerting algorithm retrospectively to the “no intervention” (i.e. 
no alerts) cases, we determined that cases randomised to MAC alerting had a statistically shorter 
mean percentage of the case that generated an alert for potentially insufficient anaesthesia than 
the “no intervention” cases (2.4% ± 7.5% versus 3.1% ± 8.5%, p=0.009).  Four of the eight 
quarters demonstrated these findings, although the remaining quarters did not reach statistical 
significance (Figure 2).  In the trend analysis by study period, the mean percentage of the case 
that triggered a potentially insufficient anaesthetic alert in the ETAC arm increased significantly 
(p <0.001) (Figure 3).  However, the mean percentage of the case that generated a BIS alert via 
the alerting algorithm did not change across the study period (p=0.38) (Figure 4).   
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Figure 2: Comparison of end-tidal anesthetic concentration alerting and ‘no intervention’ 
 
Figure 3: End-tidal anesthetic concentration alerting trend analysis 
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Figure 4: Bispectral Index alerting trend analysis 
 
Discussion 
 Population-based alerting in the prevention of AWR is important to consider because 
retrospective evidence shows that approximately 87% of all AWR cases are attributable to 
insufficient anaesthesia (Ghoneim et al., 2009).  An editorial by Nickalls and Mahajan (Nickalls 
and Mahajan, 2010) presented a parsimonious approach by stating that all cases of AWR are 
attributable to insufficient anaesthesia unless there is compelling evidence to the contrary.  They 
suggested that a population-based adequate dose for anaesthetics should be identified and 
implemented for the prevention of AWR (Nickalls and Mahajan, 2010).  In the present study, we 
analysed discrete surrogate metrics of anesthetic depth (ETAC and BIS) in order to identify a 
single diagnostic threshold for the systematic prevention of AWR.  We have demonstrated that, 
in patients undergoing general anaesthesia in which only volatile anaesthetics were used, there is 
no population-based threshold that could be used as an alert in the prevention of definite or 
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possible AWR for either ETAC or BIS. The population data from Youden’s index suggest that 
the thresholds studied would not result in the eradication of AWR.   
The thresholds that we selected were representative of what would be considered 
standard of care aaMAC for patients under general anaesthesia.  Concentrations higher than 1.0 
aaMAC were excluded from this analysis because of very high false positive alarms at thresholds 
of at least 0.7 MAC (Mashour et al., 2009a).   It is important to note that Youden’s index 
incorporates data on both sensitivity and specificity. As Table 1 indicates, lower alerting 
thresholds (e.g., higher anaesthetic concentrations) increase sensitivity at the cost of decreasing 
specificity.  Thus, including thresholds of AWR alerting beyond 1 MAC would further increase 
sensitivity, but would probably not increase Youden’s index due to the concomitant decrease in 
specificity.  In addition, the c-statistics indicated that, for both aaMAC and BIS, there was 
approximately a 50% chance (essentially random) of determining the correct threshold in the 
prevention of AWR using a population-based approach (Bewick et al., 2004).    
To date, multiple randomised controlled trials have been conducted using a population-
based alerting (or monitoring) strategy in which a specific alarm or range for ETAC or BIS was 
established for the prevention of AWR (Avidan et al., 2011; Avidan and Mashour, 2013; Avidan 
et al., 2008; Mashour et al., 2012; Myles et al., 2004).   Myles et al. found that BIS monitoring 
(maintained between 40 and 60) was associated with a relative risk reduction of 82% in surgical 
patients at high risk for AWR when compared to routine monitoring (Myles et al., 2004).  The 
next two trials used audible alerts to notify the provider of potentially insufficient anesthesia in 
patients at high risk for AWR.  Avidan et al. found that both BIS and ETAC alarms reduced 
observed awareness events compared to the expected incidence (Avidan et al., 2011; Avidan et 
al., 2008).  Mashour et al. included unselected surgical patients requiring general anesthesia and 
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demonstrated that BIS alerting protocols reduced the incidence of definite or possible AWR 
compared to no intervention (Mashour et al., 2012).  The persistence of AWR in previous trials 
suggests that population-based alerting approaches for insufficient anaesthesia will not eradicate 
AWR.  The current study adds to the literature by suggesting that it was not simply the empirical 
or arbitrary determination of alerting thresholds in past trials that failed to eradicate AWR 
because our systematic analysis and comparison suggest that no one threshold exists.  Rather 
than arguing that BIS or ETAC alerts are not useful, we would instead encourage clinicians to 
choose some threshold to prevent egregious causes of AWR (such as an empty vaporiser).  Past 
randomised controlled trials demonstrate that alerts are, in fact, associated with reduced AWR. 
At an individual level, we know that there is a specific threshold at which the patient will 
be likely to experience AWR. The identification of such a threshold will, in the future, probably 
be guided by risk factors for AWR coupled with more sophisticated monitoring.  Previous work 
has reported specific patient-based risk factors for AWR.  Further identification of risk factors, in 
conjunction with developments in monitoring the neural substrates of consciousness, must 
ultimately be incorporated into prevention strategies for AWR at an individualised level. 
 Fundamentally, individualised-based alerting strategies would not be beneficial without 
establishing evidence that real-time alarms are capable of changing behaviour.  We have 
demonstrated that real-time alerting alters the administration of anaesthetics.  When 
retrospectively applying the MAC alerting algorithm to the “no intervention” cases in the parent 
trial, the providers that were not alerted to potentially insufficient anesthesia had lower MAC 
values throughout the case than those that were actually alerted in real time.   This indicates that 
the providers receiving alerts were statistically more likely to keep the anesthetic concentration 
within the stated range for the trial and, we infer, changed their behaviour to do so.  These results 
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confirm other previously published studies that providing clinicians with alerts can drive a 
change in clinical care (Bates et al., 2001; Eden et al., 2009; Kheterpal et al., 2007; Kooij et al., 
2008; Kucher et al., 2005; O'Reilly et al., 2006; St Jacques et al., 2005; Wax et al., 2007).  
When alerting is used to notify providers to change behaviour, there is the potential for 
alert fatigue, which is defined as the provider becoming less responsive due to an alarm 
becoming bothersome or ineffective.  Alert fatigue is an increasingly prevalent phenomenon in 
the medical community, especially with the rapid advancement of electronic medical records 
(Baker, 2009; Kesselheim et al., 2011; Lee et al., 2010).   Block et al. surveyed anaesthesiologists 
practising in the USA and found that 70% of the time alarms were silenced was due to the 
perception of a false alarm (Block et al., 1999).  Only 16% of providers stated that they never 
turn off alarms (Block et al., 1999).  Therefore, it is imperative to minimise false alarms—and, 
consequently, alert fatigue—in developing an alerting strategy for AWR, a difficult task given 
the rarity of the outcome.  This is one reason why the current study focused on sensitivity and 
specificity.  We found evidence of alert fatigue as well as possible desensitisation to ETAC alerts 
across the study period.  The mean percentage of the case that generated an ETAC alert changed 
significantly during the last quarter of the trial, with alerts having increased approximately 1.2% 
from the previous quarter and 1.5% from the beginning of the study.  These data could indicate 
that the providers thought the alerts were false alarms and therefore were becoming desensitised 
and fatigued as the study continued (delayed alert fatigue).  However, these findings were only 
found in the last quarter of the study and could also be an outlier.  The BIS alerting rate was 
consistent throughout the study and showed no evidence of generating desensitisation or alert 
fatigue.   
 
93 
 
 The main limitation of this study was the small number of AWR outcomes in our 
population (n=32).  To move towards an individualized alerting approach, a multinomial logistic 
regression model must be developed that incorporates patient-specific risk factors (such as 
history of AWR (Aranake et al., 2013)) along with anaesthetic concentrations and, if possible, 
neurophysiologic indices.  Furthermore, we used the median from a 5-min period and must 
acknowledge that individual BIS or MAC values could have nonetheless fluctuated in a way that 
might not be detected with our methodology.   Finally, the current study only investigated a 
threshold using general anaesthesia with inhaled anaesthetics and is therefore not generalisable to 
cases performed using TIVA.   
 In conclusion, we could not identify a single practical threshold of ETAC or BIS values 
that can be chosen for the eradication of definite and possible AWR in a broad surgical 
population.  Although alerts have been demonstrated to prevent AWR, future work must move 
towards an individualised patient-based approach incorporating specific risk factors as well as 
monitoring the neural substrates of consciousness.  Indeed, recent studies have demonstrated 
promise in identifying correlates of anaesthetic-induced unconsciousness based on the 
neurobiology of consciousness (Casali et al., 2013; Lee et al., 2013).   Finally, we were able to 
demonstrate that providing alerts via an AIMS can influence intraoperative care, but ETAC 
alerting has the potential for desensitisation and alert fatigue.   
 
 
This is my primary body of work and was previously published in full with tables and figures by 
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Chapter 6 - Intraoperative Awareness Monitoring and Past Research 
Overview 
By conducting the largest prospective clinical trial on AWR in an unselected surgical 
adult population, it was determined that BIS alerting did not appear to be superior to MAC-based 
alarms incorporating IV anesthetics at preventing AWR events.  Through a secondary analysis of 
the traditional MAC calculations and investigating individual BIS values, it was demonstrated 
that there is no single population-based alerting algorithm using either the MAC or BIS values to 
alert the clinician in the prevention and eradication of AWR.  Therefore, the field of 
anesthesiology must move past the population-based approach in alerting for the eradication of 
AWR and develop a patient-based alerting system.    
Over the past decade, the medical community has recognized the need to develop 
enhanced monitoring techniques with the aim of preventing intraoperative awareness with recall 
(AWR).  The Joint Commission on Accreditation of Hospital Organizations issued a sentinel 
event in 2004 stating that “anesthesia awareness is under-recognized and under-treated” 
(JACHO, 2004).  They specifically recommended use of effective anesthesia monitoring tools to 
aid in the prevention of AWR (JACHO, 2004).  The American Society of Anesthesiologists 
(ASA) developed a task force in 2006 to “provide guidance for the intraoperative use of brain 
function monitors as they relate to intraoperative awareness” (ASA Task Force, 2006).  Since 
this time, several large prospective trials have been completed to determine superior methods of 
alerting clinicians to the possibility of insufficient anesthesia, which is the most common cause 
of AWR, using both anesthetic concentration monitoring and brain function monitoring (such as 
the Bispectral Index [BIS]) (Avidan et al., 2011; Avidan et al., 2008; Mashour et al., 2012; 
Myles et al., 2004; Zhang et al., 2011).   
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Anesthetic depth has traditionally been quantified for the clinician as “minimum alveolar 
concentration” (MAC).  MAC represents the concentration of anesthetic that will suppress 
movement in response to a noxious stimulus in 50% of the population, was developed for 
inhalational anesthetics only and quantifies differences in potency among the different 
inhalational agents (Eger et al., 1965).  MAC represents the partial pressure of the inhaled 
anesthetic vapor in the alveoli of the lungs (Gelb, 2009; Quasha et al., 1980).  The partial 
pressure of any vapor in the body, when at equilibrium, will be the same in all tissues in the 
body, including the brain.  Therefore, the MAC represents the partial pressure of the vapor in the 
brain, but not the actual concentration of the anesthetic vapor (Quasha et al., 1980).  Brain wave 
monitoring, derived from a processed electroencephalographic (EEG) wave, reflects the activity 
of the end organ of interest in AWR, the brain, and is not based on a pharmacologic measure.  
However, there is not one specific component of the processed EEG that can used as a predictor 
of the depth of anesthesia and the type of anesthetic used affects the EEG interpretation 
(Drummond et al., 1991).     
Starting in 2004, several prospective randomized trials were completed to investigate if 
anesthetic concentration monitoring (MAC) or EEG-based monitoring (BIS) were superior in 
prevention of AWR (Avidan et al., 2011; Avidan et al., 2008; Myles et al., 2004).  The B-Aware 
trial compared BIS monitoring to routine clinical care in a high risk surgical population for the 
prevention of AWR (Myles et al., 2004).  Myles et al. concluded that BIS monitoring reduced the 
relative risk of AWR by 82% and suggested all high risk patients should be monitored with the 
BIS (Myles et al., 2004).  The B-Aware trial did not alert the clinicians when the BIS values 
were outside a targeted range and had no active comparator in the control group.  Therefore, in 
2008 the B-Unaware trial investigated if BIS, when compared to MAC monitoring, had a lower 
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incidence of AWR in the high risk surgical population using targeted alerting mechanisms 
(Avidan et al., 2008).  Avidan et al. demonstrated no statistically significant difference in the 
incidence of AWR between the two monitoring techniques and suggested the B-Unaware trial 
did not support routine use of BIS monitoring in high risk surgical population (Avidan et al., 
2008).  Avidan et al. followed up on this finding with a multi-center BAG-RECALL trial to 
compare BIS and MAC monitoring in the prevention of awareness in high risk surgical patients 
with targeting alerting mechanisms (Avidan et al., 2011).  Once again, the superiority of BIS, 
when compared to MAC, could not be established (Avidan et al., 2011).   
The B-Aware, B-Unaware, and BAG-RECALL trials all investigated different AWR 
monitoring techniques in the high risk surgical population.  The targeted BIS values for each trial 
were based on validated research that showed 95% of patients were unconsciousness when the 
BIS value was 50 and recommended that anesthetics should be titrated to a BIS value between 40 
and 60 to prevent AWR (Glass et al., 1997).  The targeted MAC values for the B-Unaware and 
BAG-RECALL trials were based on the assumption that 0.7 MAC would general suppress 
consciousness and memory for surgical events.  The value of 0.7 MAC was chosen because 
when several anesthetic volatile agents are used in conjunction with one another an end-tidal 
anesthetic concentration (ETAC) is equated since the MAC equivalents for each agent are 
additive.  Research has demonstrated that 50% of subjects will lose responsiveness to a 
command when the ETAC is one-third of the MAC (Eger, 2001).  Therefore, if the ETAC is 
maintained above the 0.7 MAC, this may reduce AWR (Ghoneim, 2010; Gonsowski et al., 
1995).  The B-Unaware and BAG-RECALL trials restricted their anesthetics to inhalational 
agents only.  Furthermore, the B-Aware, B-Unaware, and BAG-RECALL trials did not focus on 
unselected surgical patients at all risk levels for AWR.  Finally, since many surgical cases are 
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now using a combined technique between IV and inhalational anesthetics, an “anesthetic 
concentration” concept was needed when investigating AWR prevention alerting techniques.   
Development of the Anesthetic Concentration Alert Incorporating IV Anesthetics 
 To adequately assess if alerting techniques based on MAC or BIS are superior in the 
prevention of AWR, the traditional MAC concept must also include IV anesthetics in addition to 
the inhaled anesthetics used.  Intravenous anesthetics are known to have a “MAC sparing” effect 
(Mashour et al., 2009a).  Therefore, we developed a “MAC equivalent” alert that incorporated 
the inhalational anesthetic vapor MAC with IV agents (Mashour et al., 2009a).  The algorithm 
for the “MAC equivalent” alert was based on clinical experience and was not validated or 
verified by independent measures.  Using a retrospective review, we identified 15,091 cases that 
did not have AWR and 12 cases of AWR from a generalized surgical population at a large 
tertiary academic hospital (Mashour et al., 2009a).  We retrospectively applied our “MAC 
equivalent” algorithm for both AWR and non-AWR cases to determine at which MAC 
equivalent (age-adjusted) threshold would demonstrate optimal sensitivity and specificity in the 
detection of AWR.   
In the selection of the proper threshold to use for anesthetic concentration alerting for 
future prospective trials that incorporate the effects of IV anesthetics on the MAC value, an 
optimal signal-to-noise ratio must be determined that results in a tradeoff between sensitivity and 
specificity.  We concluded that a threshold of <0.8 was most sensitive to the detection of AWR 
and had the best negative likelihood ratio but the threshold of <0.5 was associated with the best 
positive likelihood ratio (Mashour et al., 2009a).  Therefore, we selected <0.5 age-adjusted MAC 
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equivalent to be used as the alerting threshold for the Michigan Awareness Control Study 
(clinical trial NCT00689091) (Mashour et al., 2012).     
Michigan Awareness Control Study   
 The Michigan Awareness Control Study (MACS) sought to determine if a BIS or 
anesthetic concentration (adjusted for IV anesthetic effects) alerting for possible insufficient 
anesthesia would decrease the incidence of AWR in an unselected and broad surgical population 
(Mashour et al., 2012).  The results demonstrated that BIS and MAC alerting techniques did not 
differ with respect to the prevention of AWR.  However, when BIS alerting was compared 
against routine standard of care (i.e. no alerting to clinicians), we demonstrated a 4.7-fold 
reduction in definite or possible AWR (Mashour et al., 2012).  Therefore, MACS findings 
support the conclusions found in the B-Aware, B-Unaware, and BAG-RECALL trials even 
though the patient populations were different and the anesthetic concentration alerting adjusted 
for the effects of IV anesthetics.  For this trial, the anesthetic concentration alerting was based 
upon the “MAC equivalent” algorithm and is not directly comparable to the B-Unaware and 
BAG-RECALL trials.    
Systematic Analysis of Alerting Thresholds in the Prevention of AWR 
 There have been no systematic analyses of appropriate thresholds to develop population-
based alerting algorithms in the prevention of AWR.  Three trials (Avidan et al., 2011; Avidan et 
al., 2008; Mashour et al., 2012) specifically investigated AWR between two empirically derived 
alerting protocols with pre-defined thresholds.  However, there was no principled approach to 
determining the optimal alerting threshold for each of these techniques.  Therefore, we sought to 
identify a threshold for AWR alerting for both BIS and MAC monitoring using granular 
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continuous data electronically captured during the MACS trial (Shanks et al., 2014).  Since the 
“MAC equivalent” alert has not been validated, this study only used age-adjusted MAC 
(aaMAC) values. All cases that were performed under total IV anesthesia or any case that used 
an IV infusion with an inhalational anesthetic were removed for this secondary analysis (Shanks 
et al., 2014).  
 Two techniques were employed to determine an appropriate threshold for both BIS and 
aaMAC alerts using the granular data.  First, data were dichotomized based on whether a 5-
minute epoch during the surgical case was below (for aaMAC) or above (for BIS) clinically 
relevant thresholds. The sensitivity, specificity, and Youden’s Index were also calculated.  
Second, the median MAC and BIS values were individually analyzed using a receiver operator 
characteristic (ROC) curve c-statistic.  If the c-statistic was deemed adequate to demonstrate a 
discriminating capacity (>0.70), then the value for MAC and BIS with the maximum sensitivity 
and specificity would be calculated and retrospectively applied to the database.   
  Youden’s index did not demonstrate a single threshold for either aaMAC or BIS in the 
prevention of AWR (Shanks et al., 2014).  Neither c-statistic reached discriminating capacity to 
determine a threshold based on the median continuous aaMAC and BIS data (Shanks et al., 
2014).  Therefore, we have demonstrated that in patients receiving only volatile anesthetics, no 
population-based threshold can be used to alert clinicians in the prevention of AWR (Shanks et 
al., 2014). 
Future Directions of a Patient-Based Monitoring Approach in the Prevention of AWR 
The prospective clinical trials on the prevention of AWR (Avidan et al., 2011; Avidan et 
al., 2008; Mashour et al., 2012; Myles et al., 2004) and the secondary systematic analyses of 
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granular data (Shanks et al., 2014) have demonstrated that the field of anesthesiology must move 
beyond the population-based approach in prevention of AWR and towards an individualized 
patient-based approach.  The specific neuroscientific mechanisms of anesthetic-induced 
unconsciousness are beyond the scope of this project.  However, to discuss a patient-based 
monitoring approach in the prevention of AWR, a brief discussion of consciousness and 
unconsciousness within brain networks is warranted.   
Consciousness is a complex process that is poorly understood.  One current theory 
suggests that that there is a feedback of information from the frontal cortex to more primary 
sensory areas in the brain that helps select neural information for representation and 
“broadcasting” (Changeux, 2012; Dehaene and Changeux, 2011; Dehaene et al., 1998).  This 
model is referred to as the Global Neuronal Workspace (GNW).  Specifically, the GNW states 
that to form a conscious experience, there is a set of long-range excitatory axons originating with 
the pyramidal cells of the prefrontal cortex that extend towards the thalamocortical loops 
(Changeux, 2012; Dehaene and Changeux, 2011; Dehaene et al., 1998). In support of this and 
other theories related to information synthesis in the brain, anesthetics disrupt this feedback 
connectivity from the frontal cortex in association with unconsciousness (Lee et al., 2013). This 
finding is consistent with the cognitive unbinding paradigm of general anesthesia (Changeux, 
2012; Lee et al., 2009; Mashour, 2004, 2013).    
To determine accurately that a patient is unconscious during exposure to a general 
anesthetic, practical assessment of connectivity disruption is needed.  Recently Lee et al. studied 
frontal-parietal feedback connectivity disruption in surgical patients anesthetized with three 
commonly used anesthetics: ketamine, propofol and sevoflurane (Lee et al., 2013).  Eight-
channel EEG recording was conducted and normalized symbolic transfer entropy was used as an 
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analytic technique assessing directed connectivity (Lee et al., 2013).  The authors demonstrated 
that each of these molecularly and neurophysiologically diverse anesthetics disrupted feedback 
connectivity (Lee et al., 2013).  Another technique for identifying the breakdown of cortical 
connectivity and communication is the perturbational complexity index (PCI).  PCI assesses the 
EEG’s response to transcranial magnetic stimulation and is an index of the level of information 
contained in the response of the brain to the perturbation of the stimulus (Casali et al., 2013).  
The findings indicated that PCI successfully demonstrated the breakdown of cortical 
communication in anesthetized patients (Casali et al., 2013).  These two recent studies have 
demonstrated that in humans undergoing anesthesia, it is possible to demonstrate a disruption of 
cortical connectivity and communication across all major classes of anesthetics.   
Patient Monitoring Towards the Eradication of Awareness – The Next Steps 
 We have demonstrated that there is no discriminating threshold at the population-based 
level below which (aaMAC) or above which (BIS) AWR is eradicated (Shanks et al., 2014).  
Therefore, it is imperative to revise the assumptions that there is one set value for all patients to 
prevent AWR towards an individualized patient-based approach.  This study has demonstrated 
the need for patient-based algorithms in the prevention of AWR and the need to incorporate the 
neurobiology of consciousness (and unconsciousness).   One way to develop and validate a 
patient-based alerting algorithm, is to use a multivariate logistic regression model that will 
determine independent predictors of AWR.  Individual risk factors that have already been 
associated with an increased incidence of AWR will be covariates in the model, including: 
patient history of AWR (Aranake et al., 2013), high risk surgery, volume status, chronic use of 
alcohol, chronic use of opioids (either as a Boolean concept or the morphine equivalents for 
current opioid consumption), chronic use of sedative hypnotics, acute use of amphetamines, 
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female sex, age (binned by decade of life), obesity (categorized by the World Health 
Organization standards) and multiple approaches to assessing depth of anesthesia (Schneider et 
al., 2014).  The multivariate logistic regression model would need to be developed on a set of 
patients with prospectively collected data in an AIMS as well as post-operative Brice interviews 
to document the AWR event.  This would require a minimum of 200 AWR patients in the 
development database as well as another 200 patients in the validation database to follow the rule 
of 10 which was developed to prevent overfitting the logistic regression model and states that for 
every covariate placed into a model, there must be at least 10 patients with the outcome of 
interest (AWR) (Harrell et al., 1984).  When a model is overfit, the results may be “fitting” the 
noise and not the actual signal or the true underlying covariates that are independent predictors 
of AWR and can be used in patient-based alerting algorithms.  Currently there are no trials that 
have been conducted that would allow this level of modeling to be performed properly.  Once the 
data are available, the independent risk factors that are identified, and validated, can then be 
programmed into an AIMS system to risk-adjust and alert clinicians on a patient-based level for 
the prevention of AWR.   
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Appendix I: Actual SQL code for Alerting Algorithms   
Below is the actual SQL code running in real-time within the Centricity (GE Healthcare®) 
database to alert providers when the median anesthetic concentration <0.5 or the median BIS 
value was >60 for a 5 minute period 
Anesthetic Concentration Alert Algorithm 
IF @age_in_years <= 39 
    SELECT  @sevo_mac = 2.4 , 
            @iso_mac = 1.3 , 
            @halo_mac = 0.9 , 
            @des_mac = 7.0 , 
            @nitrous_mac = 105 
IF @age_in_years >= 40    AND @age_in_years <= 59 
    SELECT  @sevo_mac = 1.7 , 
            @iso_mac = 1.1 , 
            @halo_mac = 0.75 , 
            @des_mac = 6.0 , 
            @nitrous_mac = 105 
IF @age_in_years >= 60    AND @age_in_years <= 79 
    SELECT  @sevo_mac = 1.5 , 
            @iso_mac = 1.0 , 
            @halo_mac = 0.7 , 
            @des_mac = 5.2 , 
            @nitrous_mac = 105 
IF @age_in_years >= 80 
    SELECT  @sevo_mac = 1.2 , 
            @iso_mac = 0.8 , 
            @halo_mac = 0.65 , 
            @des_mac = 4.5 , 
            @nitrous_mac = 105 
 
 
SELECT  @total_mac = ( ( @sevo_conc / @sevo_mac ) + ( @iso_conc / @iso_mac ) 
                       + ( @des_conc / @des_mac ) + ( @nitrous_conc 
                                                      / @nitrous_mac ) )  
 
 
IF @total_mac <= @mac_threshold 
    BEGIN 
     
  --GET THE CURRENT DEX Rate 
  
        IF @dex_rate >= 0.2 
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            AND @dex_rate IS NOT NULL 
            BEGIN 
 
                SELECT  @total_mac = ( ( ( @sevo_conc / @sevo_mac ) * 2 ) 
                                       + ( ( @iso_conc / @iso_mac ) * 2 ) 
                                       + ( ( @des_conc / @des_mac ) * 2 ) 
                                       + ( ( @nitrous_conc / @nitrous_mac ) 
                                           * 2 ) )  
  
            END 
    END  
 
IF @Total_mac <= @mac_threshold 
    BEGIN 
        IF @et_co2 < 5 
            BEGIN 
   -- looks like mon cap is dead or that there is no sampling going on.   
   -- no need to alert 
                SELECT  @no_etco2 = 1 
            END 
        ELSE 
            SELECT  @no_etco2 = 0  
 
    END 
 
IF @total_mac <= @mac_threshold AND @no_etco2 = 0 
    BEGIN 
        
    --GET THE CURRENT Propofol Infusion Rate 
  
 
        IF @propofol_rate <> 0 
            AND @propofol_rate IS NOT NULL 
            SELECT  @total_mac = @total_mac + ( @propofol_rate / 150 ) 
 
--     print 'in propofol' 
--     select @propofol_rate, @patient_sys, @visit_sys, @op_sys, 
@op_date, @time_end 
    END 
 
if @total_mac <= @mac_threshold and @no_etco2=0 
   begin 
  -- check to see if there is a recent propofol, midaz, etomidate, thiopental bolus 
   
 
  --if exists recent propofol, midaz, etomidate, thiopental bolus 
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   SELECT @hypnotic_bolus_yn=1 
  --else 
   select @hypnotic_bolus_yn =0 
    end  
 
 
if @room_number_int % 2 = 0  --Even Rooms 
  begin 
 
    select @bis_room_yn =1 
    select @mac_room_yn = 0 
 
  end 
  else --Odd Rooms 
  begin 
 
    select @bis_room_yn =0 
    select @mac_room_yn =1 
 
  END 
   
 
if @total_mac <= @mac_threshold   and @no_etco2=0  
  select @mac_alert_yn=1 
 
IF @mac_room_yn = 1 AND @mac_alert_yn = 1 
BEGIN 
 
 --If user has NOT choosen to "suspend" alerts for 15 minutes: 
 
 --Page user of a MAC alert 
END 
 
BIS Alert Algorithm 
if @bis_value > @bis_threshold  
  select @bis_alert_yn=1 
 
IF @bis_room_yn = 1 AND @bis_alert_yn = 1 
BEGIN 
 --If user has NOT choosen to "suspend" alerts for 15 minutes: 
 
 --Page user of a BIS alert 
END 
 
 
--Insert alert into log table of all alerts. 
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Appendix II: Actual SPSS outputs for Chapter 4 MACS Trial 
BIS_MAC_org * Definite_Awareness 
Crosstab 
 
Definite_Awareness 
Total No 
Definite 
Awareness 
BIS_MAC_org BIS Count 9452 8 9460 
% within BIS_MAC_org 99.9% .1% 100.0% 
% within Definite_Awareness 50.2% 42.1% 50.2% 
% of Total 50.2% .0% 50.2% 
MAC Count 9365 11 9376 
% within BIS_MAC_org 99.9% .1% 100.0% 
% within Definite_Awareness 49.8% 57.9% 49.8% 
% of Total 49.7% .1% 49.8% 
Total Count 18817 19 18836 
% within BIS_MAC_org 99.9% .1% 100.0% 
% within Definite_Awareness 100.0% 100.0% 100.0% 
% of Total 99.9% .1% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .501a 1 .479   
Continuity Correctionb .229 1 .632   
Likelihood Ratio .503 1 .478   
Fisher's Exact Test    .501 .317 
Linear-by-Linear Association .501 1 .479   
N of Valid Cases 18836     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 9.46. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 
Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for BIS_MAC_org 
(BIS / MAC) 
1.388 .558 3.452 
For cohort 
Definite_Awareness = No 
1.000 .999 1.001 
For cohort 
Definite_Awareness = Definite 
Awareness 
.721 .290 1.791 
N of Valid Cases 18836   
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BIS_MAC_org * Awareness 
Crosstab 
 
Awareness 
Total No Definite Possible 
BIS_MAC_org BIS Count 9442 8 10 9460 
% within BIS_MAC_org 99.8% .1% .1% 100.0% 
% within Awareness 50.2% 42.1% 55.6% 50.2% 
% of Total 50.1% .0% .1% 50.2% 
MAC Count 9357 11 8 9376 
% within BIS_MAC_org 99.8% .1% .1% 100.0% 
% within Awareness 49.8% 57.9% 44.4% 49.8% 
% of Total 49.7% .1% .0% 49.8% 
Total Count 18799 19 18 18836 
% within BIS_MAC_org 99.8% .1% .1% 100.0% 
% within Awareness 100.0% 100.0% 100.0% 100.0% 
% of Total 99.8% .1% .1% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square .706a 2 .703 
Likelihood Ratio .708 2 .702 
Linear-by-Linear Association .006 1 .937 
N of Valid Cases 18836   
a. 0 cells (.0%) have expected count less than 5. The minimum expected  
 
BIS_MAC_org * Definite_or_Possible_Awareness 
Crosstab 
 
Definite_or_Possible_Awareness 
Total No 
Definite or 
Possible 
Awareness 
BIS_MAC_org BIS Count 9442 18 9460 
% within BIS_MAC_org 99.8% .2% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
50.2% 48.6% 50.2% 
% of Total 50.1% .1% 50.2% 
MAC Count 9357 19 9376 
% within BIS_MAC_org 99.8% .2% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
49.8% 51.4% 49.8% 
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% of Total 49.7% .1% 49.8% 
Total Count 18799 37 18836 
% within BIS_MAC_org 99.8% .2% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
100.0% 100.0% 100.0% 
% of Total 99.8% .2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .037a 1 .848   
Continuity Correctionb .001 1 .978   
Likelihood Ratio .037 1 .848   
Fisher's Exact Test    .871 .489 
Linear-by-Linear Association .037 1 .848   
N of Valid Cases 18836     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 18.42. 
b. Computed only for a 2x2 table 
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Risk Estimate 
 
Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for BIS_MAC_org 
(BIS / MAC) 
1.065 .559 2.031 
For cohort 
Definite_or_Possible_Awaren
ess = No 
1.000 .999 1.001 
For cohort 
Definite_or_Possible_Awaren
ess = Definite or Possible 
Awareness 
.939 .493 1.788 
N of Valid Cases 18836   
 
New_groups * Definite_Awareness 
Crosstab 
 
Definite_Awareness 
Total No 
Definite 
Awareness 
New_groups MAC Count 9365 11 9376 
% within New_groups 99.9% .1% 100.0% 
% within Definite_Awareness 49.8% 57.9% 49.8% 
% of Total 49.7% .1% 49.8% 
BIS with BIS Count 6073 3 6076 
% within New_groups 100.0% .0% 100.0% 
% within Definite_Awareness 32.3% 15.8% 32.3% 
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% of Total 32.2% .0% 32.3% 
BIS no BIS Count 3379 5 3384 
% within New_groups 99.9% .1% 100.0% 
% within Definite_Awareness 18.0% 26.3% 18.0% 
% of Total 17.9% .0% 18.0% 
Total Count 18817 19 18836 
% within New_groups 99.9% .1% 100.0% 
% within Definite_Awareness 100.0% 100.0% 100.0% 
% of Total 99.9% .1% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 2.589a 2 .274 
Likelihood Ratio 2.857 2 .240 
Linear-by-Linear Association .000 1 .989 
N of Valid Cases 18836   
a. 1 cells (16.7%) have expected count less than 5. The minimum expected 
count is 3.41. 
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New_groups * Awareness 
Crosstab 
 
Awareness 
Total No Definite Possible 
New_groups MAC Count 9357 11 8 9376 
% within New_groups 99.8% .1% .1% 100.0% 
% within Awareness 49.8% 57.9% 44.4% 49.8% 
% of Total 49.7% .1% .0% 49.8% 
BIS with BIS Count 6071 3 2 6076 
% within New_groups 99.9% .0% .0% 100.0% 
% within Awareness 32.3% 15.8% 11.1% 32.3% 
% of Total 32.2% .0% .0% 32.3% 
BIS no BIS Count 3371 5 8 3384 
% within New_groups 99.6% .1% .2% 100.0% 
% within Awareness 17.9% 26.3% 44.4% 18.0% 
% of Total 17.9% .0% .0% 18.0% 
Total Count 18799 19 18 18836 
% within New_groups 99.8% .1% .1% 100.0% 
% within Awareness 100.0% 100.0% 100.0% 100.0% 
% of Total 99.8% .1% .1% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 12.229a 4 .016 
Likelihood Ratio 11.290 4 .023 
Linear-by-Linear Association 2.525 1 .112 
N of Valid Cases 18836   
a. 2 cells (22.2%) have expected count less than 5. The minimum expected 
count is 3.23. 
 
 
New_groups * Definite_or_Possible_Awareness 
Crosstab 
 
Definite_or_Possible_Awareness 
Total No 
Definite or 
Possible 
Awareness 
New_groups MAC Count 9357 19 9376 
% within New_groups 99.8% .2% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
49.8% 51.4% 49.8% 
% of Total 49.7% .1% 49.8% 
BIS with BIS Count 6071 5 6076 
% within New_groups 99.9% .1% 100.0% 
% within 32.3% 13.5% 32.3% 
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Definite_or_Possible_Awarene
ss 
% of Total 32.2% .0% 32.3% 
BIS no BIS Count 3371 13 3384 
% within New_groups 99.6% .4% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
17.9% 35.1% 18.0% 
% of Total 17.9% .1% 18.0% 
Total Count 18799 37 18836 
% within New_groups 99.8% .2% 100.0% 
% within 
Definite_or_Possible_Awarene
ss 
100.0% 100.0% 100.0% 
% of Total 99.8% .2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 10.139a 2 .006 
Likelihood Ratio 9.942 2 .007 
Linear-by-Linear Association 1.565 1 .211 
N of Valid Cases 18836   
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 6.65. 
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Definite_Awareness 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid No 18817 99.9 99.9 99.9 
Definite Awareness 19 .1 .1 100.0 
Total 18836 100.0 100.0  
 
USE ALL. 
COMPUTE filter_$=(Definite_or_Possible_Awareness = 1). 
VARIABLE LABEL filter_$ 'Definite_or_Possible_Awareness = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMAT filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
 
CROSSTABS 
  /TABLES=New_groups BY Distress_Awareness_Class 
  /FORMAT=AVALUE TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW COLUMN TOTAL 
  /COUNT ROUND CELL. 
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New_groups * Distress_Awareness_Class Crosstabulation 
 
Distress_Awareness_Class 
Total 0 1 
New_groups MAC Count 16 3 19 
% within New_groups 84.2% 15.8% 100.0% 
% within 
Distress_Awareness_Class 
57.1% 33.3% 51.4% 
% of Total 43.2% 8.1% 51.4% 
BIS with BIS Count 2 3 5 
% within New_groups 40.0% 60.0% 100.0% 
% within 
Distress_Awareness_Class 
7.1% 33.3% 13.5% 
% of Total 5.4% 8.1% 13.5% 
BIS no BIS Count 10 3 13 
% within New_groups 76.9% 23.1% 100.0% 
% within 
Distress_Awareness_Class 
35.7% 33.3% 35.1% 
% of Total 27.0% 8.1% 35.1% 
Total Count 28 9 37 
% within New_groups 75.7% 24.3% 100.0% 
% within 
Distress_Awareness_Class 
100.0% 100.0% 100.0% 
% of Total 75.7% 24.3% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 4.220a 2 .121 
Likelihood Ratio 3.705 2 .157 
Linear-by-Linear Association .363 1 .547 
N of Valid Cases 37   
a. 4 cells (66.7%) have expected count less than 5. The minimum expected 
count is 1.22. 
FILTER OFF. 
USE ALL. 
EXECUTE. 
FREQUENCIES VARIABLES=Class_Awareness 
  /ORDER=ANALYSIS. 
Frequencies 
Class_Awareness 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid   18799 99.8 99.8 99.8 
1 16 .1 .1 99.9 
2 8 .0 .0 99.9 
2D 4 .0 .0 100.0 
3 3 .0 .0 100.0 
3D 2 .0 .0 100.0 
4 1 .0 .0 100.0 
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4D 2 .0 .0 100.0 
5D 1 .0 .0 100.0 
Total 18836 100.0 100.0  
 
COMPUTE filter_$=(gas_analyzer_problem = 0). 
VARIABLE LABELS filter_$ 'gas_analyzer_problem = 0 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups medianMAC DISPLAY=LABEL 
  /TABLE New_groups BY medianMAC [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
medianMAC 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC .9391 .2648 .9400 .7905 1.1110 9083 
BIS with BIS .9372 .2599 .9400 .8105 1.1110 5956 
BIS no BIS .9108 .2771 .9400 .7690 1.0760 3272 
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*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (medianMAC) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Induction_propofol DISPLAY=LABEL 
  /TABLE New_groups [C] BY Induction_propofol [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN 
    F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
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Custom Tables 
 
Induction_propofol 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 156 67 160 120 200 9225 
BIS with BIS 158 66 160 120 200 6021 
BIS no BIS 153 68 150 120 200 3319 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Induction_propofol) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
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* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Intraop_propofol DISPLAY=LABEL 
  /TABLE New_groups [C] BY Intraop_propofol [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN 
F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
Intraop_propofol 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 167 78 170 130 200 9225 
BIS with BIS 171 77 180 130 200 6021 
BIS no BIS 164 79 170 120 200 3319 
 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Intraop_propofol) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
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Nonparametric Tests 
 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Total_Midaz_use DISPLAY=LABEL 
  /TABLE New_groups [C] BY Total_Midaz_use [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN 
F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
Total_Midaz_use 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 2.99 3.09 2.00 2.00 4.00 9225 
BIS with BIS 3.12 3.35 2.00 2.00 4.00 6021 
BIS no BIS 2.97 2.98 2.00 2.00 4.00 3319 
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*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Total_Midaz_use) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Intraop_Fentanyl DISPLAY=LABEL 
  /TABLE New_groups [C] BY Intraop_Fentanyl [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN 
F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
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Custom Tables 
 
Intraop_Fentanyl 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 203.0 193.2 175.0 100.0 250.0 9225 
BIS with BIS 216.3 214.9 200.0 100.0 250.0 6021 
BIS no BIS 188.7 196.0 150.0 100.0 250.0 3319 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Intraop_Fentanyl) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
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* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Intraop_Morphine DISPLAY=LABEL 
  /TABLE New_groups [C] BY Intraop_Morphine [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN 
F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
Intraop_Morphine 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 2.7 4.4 .0 .0 5.0 9223 
BIS with BIS 3.0 4.7 .0 .0 5.0 6019 
BIS no BIS 2.1 4.1 .0 .0 3.0 3318 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Intraop_Morphine) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
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Nonparametric Tests 
 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups PACU_time DISPLAY=LABEL 
  /TABLE New_groups [C] BY PACU_time [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75, VALIDN F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
PACU_time 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 112.64 69.13 98.00 66.00 140.00 8401 
BIS with BIS 109.48 65.84 95.00 64.00 138.00 5473 
BIS no BIS 107.27 63.37 94.00 64.00 133.00 2990 
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*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (PACU_time) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
 
CROSSTABS 
  /TABLES=New_groups BY PACU_Nausea_yn PACU_Vomit_yn 
  /FORMAT=AVALUE TABLES 
  /STATISTICS=CHISQ RISK 
  /CELLS=COUNT ROW COLUMN TOTAL 
  /COUNT ROUND CELL. 
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Crosstabs 
New_groups * PACU_Nausea_yn 
Crosstab 
 
PACU_Nausea_yn 
Total None Yes 
New_groups MAC Count 6184 511 6695 
% within New_groups 92.4% 7.6% 100.0% 
% within PACU_Nausea_yn 49.4% 50.5% 49.5% 
% of Total 45.7% 3.8% 49.5% 
BIS with BIS Count 4042 324 4366 
% within New_groups 92.6% 7.4% 100.0% 
% within PACU_Nausea_yn 32.3% 32.0% 32.3% 
% of Total 29.9% 2.4% 32.3% 
BIS no BIS Count 2286 177 2463 
% within New_groups 92.8% 7.2% 100.0% 
% within PACU_Nausea_yn 18.3% 17.5% 18.2% 
% of Total 16.9% 1.3% 18.2% 
Total Count 12512 1012 13524 
% within New_groups 92.5% 7.5% 100.0% 
% within PACU_Nausea_yn 100.0% 100.0% 100.0% 
% of Total 92.5% 7.5% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square .554a 2 .758 
Likelihood Ratio .556 2 .757 
Linear-by-Linear Association .553 1 .457 
N of Valid Cases 13524   
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 184.31. 
 
New_groups * PACU_Vomit_yn 
Crosstab 
 
PACU_Vomit_yn 
Total None Yes 
New_groups MAC Count 7149 83 7232 
% within New_groups 98.9% 1.1% 100.0% 
% within PACU_Vomit_yn 49.7% 49.4% 49.7% 
% of Total 49.2% .6% 49.7% 
BIS with BIS Count 4617 52 4669 
% within New_groups 98.9% 1.1% 100.0% 
% within PACU_Vomit_yn 32.1% 31.0% 32.1% 
% of Total 31.7% .4% 32.1% 
BIS no BIS Count 2608 33 2641 
% within New_groups 98.8% 1.2% 100.0% 
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% within PACU_Vomit_yn 18.1% 19.6% 18.2% 
% of Total 17.9% .2% 18.2% 
Total Count 14374 168 14542 
% within New_groups 98.8% 1.2% 100.0% 
% within PACU_Vomit_yn 100.0% 100.0% 100.0% 
% of Total 98.8% 1.2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square .280a 2 .869 
Likelihood Ratio .275 2 .871 
Linear-by-Linear Association .096 1 .757 
N of Valid Cases 14542   
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 30.51. 
 
FILTER OFF. 
USE ALL. 
EXECUTE. 
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Median_BIS 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N 
New_groups MAC 41.2 10.5 40.0 34.0 46.0 3816 
BIS with BIS 40.4 8.7 40.0 35.0 44.5 6021 
BIS no BIS . . . . . 0 
 
USE ALL. 
COMPUTE filter_$=(TIVA = 1). 
VARIABLE LABELS filter_$ 'TIVA = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Intraop_propofol_infusionCC DISPLAY=LABEL 
  /TABLE New_groups [C] BY Intraop_propofol_infusionCC [MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 75] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
 
 
 
 
 
133 
 
Custom Tables 
 
 
Intraop_propofol_infusionCC 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 
New_groups MAC 107.1053 72.7028 94.2820 51.3970 144.8070 
BIS with BIS 120.4140 107.4353 84.8270 50.5570 157.3660 
BIS no BIS 69.2697 43.6690 57.9475 37.1250 100.3430 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Intraop_propofol_infusionCC) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
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USE ALL. 
COMPUTE filter_$=(TIVA = 1). 
VARIABLE LABELS filter_$ 'TIVA = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups Intraop_propofol_infusionCC DISPLAY=LABEL 
  /TABLE New_groups [C] BY Intraop_propofol_infusionCC [S][MEAN, STDDEV, MEDIAN, PTILE 25, PTILE 
75, VALIDN F40.0, TOTALN F40.0] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE. 
 
Custom Tables 
 
 
Intraop_propofol_infusionCC 
Mean 
Standard 
Deviation Median Percentile 25 Percentile 75 Valid N Total N 
New_groups MAC 107.1053 72.7028 94.2820 51.3970 144.8070 129 131 
BIS with BIS 120.4140 107.4353 84.8270 50.5570 157.3660 58 58 
BIS no BIS 69.2697 43.6690 57.9475 37.1250 100.3430 42 42 
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APPENDIX III: Actual SPSS outputs for Chapter 5 
New_groups * Definite_or_Possible_Awareness Crosstabulation 
 Definite_or_Possible_Awareness Total 
No Definite or Possible 
Awareness 
New_groups 
MAC 
Count 8021 15 8036 
% within New_groups 99.8% 0.2% 100.0% 
% within 
Definite_or_Possible_Awareness 
50.0% 46.9% 50.0% 
% of Total 49.9% 0.1% 50.0% 
BIS with 
BIS 
Count 5169 5 5174 
% within New_groups 99.9% 0.1% 100.0% 
% within 
Definite_or_Possible_Awareness 
32.2% 15.6% 32.2% 
% of Total 32.2% 0.0% 32.2% 
BIS no BIS 
Count 2846 12 2858 
% within New_groups 99.6% 0.4% 100.0% 
% within 
Definite_or_Possible_Awareness 
17.7% 37.5% 17.8% 
% of Total 17.7% 0.1% 17.8% 
Total 
Count 16036 32 16068 
% within New_groups 99.8% 0.2% 100.0% 
% within 
Definite_or_Possible_Awareness 
100.0% 100.0% 100.0% 
% of Total 99.8% 0.2% 100.0% 
 
136 
 
Crosstabs 
 
Definite_Awareness * BIS_60_alert_triggered_yn 
Crosstab 
 BIS_60_alert_triggered_yn Total 
No BIS >60 BIS >60 at least 
once 
Definite_Awareness 
No 
Count 3750 1401 5151 
% within Definite_Awareness 72.8% 27.2% 100.0% 
% within 
BIS_60_alert_triggered_yn 
99.9% 99.9% 99.9% 
% of Total 72.8% 27.2% 99.9% 
Definite Awareness 
Count 2 1 3 
% within Definite_Awareness 66.7% 33.3% 100.0% 
% within 
BIS_60_alert_triggered_yn 
0.1% 0.1% 0.1% 
% of Total 0.0% 0.0% 0.1% 
Total 
Count 3752 1402 5154 
% within Definite_Awareness 72.8% 27.2% 100.0% 
% within 
BIS_60_alert_triggered_yn 
100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .057a 1 .811   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .055 1 .815   
Fisher's Exact Test    1.000 .614 
Linear-by-Linear 
Association 
.057 1 .811 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .82. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for Definite_Awareness 
(No / Definite Awareness) 
1.338 .121 14.771 
For cohort BIS_60_alert_triggered_yn 
= No BIS >60 
1.092 .491 2.431 
For cohort BIS_60_alert_triggered_yn 
= BIS >60 at least once 
.816 .165 4.045 
N of Valid Cases 5154   
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Definite_Awareness * BIS_70_yn 
Crosstab 
 BIS_70_yn Total 
.00 1.00 
Definite_Awarenes
s 
No 
Count 4744 407 5151 
% within 
Definite_Awareness 
92.1% 7.9% 100.0% 
% within BIS_70_yn 99.9% 100.0% 99.9% 
% of Total 92.0% 7.9% 99.9% 
Definite Awareness 
Count 3 0 3 
% within 
Definite_Awareness 
100.0% 0.0% 100.0% 
% within BIS_70_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 4747 407 5154 
% within 
Definite_Awareness 
92.1% 7.9% 100.0% 
% within BIS_70_yn 100.0% 100.0% 100.0% 
% of Total 92.1% 7.9% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .257a 1 .612   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .494 1 .482   
Fisher's Exact Test    1.000 .781 
Linear-by-Linear 
Association 
.257 1 .612 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .24. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_70_yn = .00 .921 .914 .928 
N of Valid Cases 5154   
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Definite_Awareness * BIS_80_yn 
Crosstab 
 BIS_80_yn Total 
.00 1.00 
Definite_Awarenes
s 
No 
Count 5017 134 5151 
% within 
Definite_Awareness 
97.4% 2.6% 100.0% 
% within BIS_80_yn 99.9% 100.0% 99.9% 
% of Total 97.3% 2.6% 99.9% 
Definite Awareness 
Count 3 0 3 
% within 
Definite_Awareness 
100.0% 0.0% 100.0% 
% within BIS_80_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 5020 134 5154 
% within 
Definite_Awareness 
97.4% 2.6% 100.0% 
% within BIS_80_yn 100.0% 100.0% 100.0% 
% of Total 97.4% 2.6% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .080a 1 .777   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .158 1 .691   
Fisher's Exact Test    1.000 .924 
Linear-by-Linear 
Association 
.080 1 .777 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .08. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_80_yn = .00 .974 .970 .978 
N of Valid Cases 5154   
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Definite_Awareness * BIS_90_yn 
Crosstab 
 BIS_90_yn Total 
.00 1.00 
Definite_Awarenes
s 
No 
Count 5113 38 5151 
% within 
Definite_Awareness 
99.3% 0.7% 100.0% 
% within BIS_90_yn 99.9% 100.0% 99.9% 
% of Total 99.2% 0.7% 99.9% 
Definite Awareness 
Count 3 0 3 
% within 
Definite_Awareness 
100.0% 0.0% 100.0% 
% within BIS_90_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 5116 38 5154 
% within 
Definite_Awareness 
99.3% 0.7% 100.0% 
% within BIS_90_yn 100.0% 100.0% 100.0% 
% of Total 99.3% 0.7% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .022a 1 .881   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .044 1 .833   
Fisher's Exact Test    1.000 .978 
Linear-by-Linear 
Association 
.022 1 .881 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .02. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_90_yn = .00 .993 .990 .995 
N of Valid Cases 5154   
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Definite_Awareness * BIS_50_yn 
Crosstab 
 BIS_50_yn Total 
.00 1.00 
Definite_Awarenes
s 
No 
Count 2489 2662 5151 
% within 
Definite_Awareness 
48.3% 51.7% 100.0% 
% within BIS_50_yn 100.0% 99.9% 99.9% 
% of Total 48.3% 51.6% 99.9% 
Definite Awareness 
Count 1 2 3 
% within 
Definite_Awareness 
33.3% 66.7% 100.0% 
% within BIS_50_yn 0.0% 0.1% 0.1% 
% of Total 0.0% 0.0% 0.1% 
Total 
Count 2490 2664 5154 
% within 
Definite_Awareness 
48.3% 51.7% 100.0% 
% within BIS_50_yn 100.0% 100.0% 100.0% 
% of Total 48.3% 51.7% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .270a 1 .604   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .276 1 .599   
Fisher's Exact Test    1.000 .525 
Linear-by-Linear 
Association 
.270 1 .604 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.45. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for Definite_Awareness 
(No / Definite Awareness) 
1.870 .169 20.636 
For cohort BIS_50_yn = .00 1.450 .293 7.184 
For cohort BIS_50_yn = 1.00 .775 .348 1.726 
N of Valid Cases 5154   
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Definite_or_Possible_Awareness * BIS_60_alert_triggered_yn 
Crosstab 
 BIS_60_alert_triggered_yn Total 
No BIS >60 BIS >60 at least 
once 
Definite_or_Possible_Awarene
ss 
No 
Count 3748 1401 5149 
% within 
Definite_or_Possible_Awarenes
s 
72.8% 27.2% 100.0% 
% within 
BIS_60_alert_triggered_yn 
99.9% 99.9% 99.9% 
% of Total 72.7% 27.2% 99.9% 
Definite or Possible 
Awareness 
Count 4 1 5 
% within 
Definite_or_Possible_Awarenes
s 
80.0% 20.0% 100.0% 
% within 
BIS_60_alert_triggered_yn 
0.1% 0.1% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 3752 1402 5154 
% within 
Definite_or_Possible_Awarenes
s 
72.8% 27.2% 100.0% 
% within 
BIS_60_alert_triggered_yn 
100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .131a 1 .717   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .140 1 .709   
Fisher's Exact Test    1.000 .586 
Linear-by-Linear 
Association 
.131 1 .717 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.36. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for 
Definite_or_Possible_Awareness (No / 
Definite or Possible Awareness) 
.669 .075 5.989 
For cohort BIS_60_alert_triggered_yn 
= No BIS >60 
.910 .587 1.411 
For cohort BIS_60_alert_triggered_yn 
= BIS >60 at least once 
1.360 .236 7.857 
N of Valid Cases 5154   
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Definite_or_Possible_Awareness * BIS_70_yn 
Crosstab 
 BIS_70_yn Total 
.00 1.00 
Definite_or_Possible_Awarenes
s 
No 
Count 4742 407 5149 
% within 
Definite_or_Possible_Awareness 
92.1% 7.9% 100.0% 
% within BIS_70_yn 99.9% 100.0% 99.9% 
% of Total 92.0% 7.9% 99.9% 
Definite or Possible 
Awareness 
Count 5 0 5 
% within 
Definite_or_Possible_Awareness 
100.0% 0.0% 100.0% 
% within BIS_70_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 4747 407 5154 
% within 
Definite_or_Possible_Awareness 
92.1% 7.9% 100.0% 
% within BIS_70_yn 100.0% 100.0% 100.0% 
% of Total 92.1% 7.9% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .429a 1 .512   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .823 1 .364   
Fisher's Exact Test    1.000 .663 
Linear-by-Linear 
Association 
.429 1 .512 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .39. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_70_yn = .00 .921 .914 .928 
N of Valid Cases 5154   
 
 
 
 
 
 
 
150 
 
Definite_or_Possible_Awareness * BIS_80_yn 
Crosstab 
 BIS_80_yn Total 
.00 1.00 
Definite_or_Possible_Awarenes
s 
No 
Count 5015 134 5149 
% within 
Definite_or_Possible_Awareness 
97.4% 2.6% 100.0% 
% within BIS_80_yn 99.9% 100.0% 99.9% 
% of Total 97.3% 2.6% 99.9% 
Definite or Possible 
Awareness 
Count 5 0 5 
% within 
Definite_or_Possible_Awareness 
100.0% 0.0% 100.0% 
% within BIS_80_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 5020 134 5154 
% within 
Definite_or_Possible_Awareness 
97.4% 2.6% 100.0% 
% within BIS_80_yn 100.0% 100.0% 100.0% 
% of Total 97.4% 2.6% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .134a 1 .715   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .264 1 .608   
Fisher's Exact Test    1.000 .877 
Linear-by-Linear 
Association 
.134 1 .715 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .13. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_80_yn = .00 .974 .970 .978 
N of Valid Cases 5154   
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Definite_or_Possible_Awareness * BIS_90_yn 
Crosstab 
 BIS_90_yn Total 
.00 1.00 
Definite_or_Possible_Awarenes
s 
No 
Count 5111 38 5149 
% within 
Definite_or_Possible_Awareness 
99.3% 0.7% 100.0% 
% within BIS_90_yn 99.9% 100.0% 99.9% 
% of Total 99.2% 0.7% 99.9% 
Definite or Possible 
Awareness 
Count 5 0 5 
% within 
Definite_or_Possible_Awareness 
100.0% 0.0% 100.0% 
% within BIS_90_yn 0.1% 0.0% 0.1% 
% of Total 0.1% 0.0% 0.1% 
Total 
Count 5116 38 5154 
% within 
Definite_or_Possible_Awareness 
99.3% 0.7% 100.0% 
% within BIS_90_yn 100.0% 100.0% 100.0% 
% of Total 99.3% 0.7% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .037a 1 .847   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .074 1 .786   
Fisher's Exact Test    1.000 .964 
Linear-by-Linear 
Association 
.037 1 .847 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .04. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort BIS_90_yn = .00 .993 .990 .995 
N of Valid Cases 5154   
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Definite_or_Possible_Awareness * BIS_50_yn 
Crosstab 
 BIS_50_yn Total 
.00 1.00 
Definite_or_Possible_Awarenes
s 
No 
Count 2488 2661 5149 
% within 
Definite_or_Possible_Awareness 
48.3% 51.7% 100.0% 
% within BIS_50_yn 99.9% 99.9% 99.9% 
% of Total 48.3% 51.6% 99.9% 
Definite or Possible 
Awareness 
Count 2 3 5 
% within 
Definite_or_Possible_Awareness 
40.0% 60.0% 100.0% 
% within BIS_50_yn 0.1% 0.1% 0.1% 
% of Total 0.0% 0.1% 0.1% 
Total 
Count 2490 2664 5154 
% within 
Definite_or_Possible_Awareness 
48.3% 51.7% 100.0% 
% within BIS_50_yn 100.0% 100.0% 100.0% 
% of Total 48.3% 51.7% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .138a 1 .710   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .140 1 .709   
Fisher's Exact Test    1.000 .532 
Linear-by-Linear 
Association 
.138 1 .710 
  
N of Valid Cases 5154     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.42. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for 
Definite_or_Possible_Awareness (No / 
Definite or Possible Awareness) 
1.402 .234 8.400 
For cohort BIS_50_yn = .00 1.208 .413 3.536 
For cohort BIS_50_yn = 1.00 .861 .421 1.763 
N of Valid Cases 5154   
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New_groups * AAMAC_0.4_yn 
Crosstab 
 AAMAC_0.4_yn Total 
No AAMAC<0.4 
alerts 
1+ AAMAC <0.4 
alerts 
New_group
s 
MAC 
Count 6397 1639 8036 
% within 
New_groups 
79.6% 20.4% 100.0% 
% within 
AAMAC_0.4_yn 
74.3% 71.6% 73.8% 
% of Total 58.7% 15.0% 73.8% 
BIS no 
BIS 
Count 2209 649 2858 
% within 
New_groups 
77.3% 22.7% 100.0% 
% within 
AAMAC_0.4_yn 
25.7% 28.4% 26.2% 
% of Total 20.3% 6.0% 26.2% 
Total 
Count 8606 2288 10894 
% within 
New_groups 
79.0% 21.0% 100.0% 
% within 
AAMAC_0.4_yn 
100.0% 100.0% 100.0% 
% of Total 79.0% 21.0% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 6.795a 1 .009   
Continuity Correctionb 6.656 1 .010   
Likelihood Ratio 6.712 1 .010   
Fisher's Exact Test    .009 .005 
Linear-by-Linear 
Association 
6.794 1 .009 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 600.25. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.147 1.034 1.271 
For cohort AAMAC_0.4_yn = No 
AAMAC<0.4 alerts 
1.030 1.007 1.054 
For cohort AAMAC_0.4_yn = 1+ 
AAMAC <0.4 alerts 
.898 .829 .973 
N of Valid Cases 10894   
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New_groups * AAMAC_0.5_yn 
Crosstab 
 AAMAC_0.5_yn Total 
No AAMAC<0.5 
alerts 
1+ AAMAC <0.5 
alerts 
New_group
s 
MAC 
Count 5673 2363 8036 
% within 
New_groups 
70.6% 29.4% 100.0% 
% within 
AAMAC_0.5_yn 
74.2% 72.7% 73.8% 
% of Total 52.1% 21.7% 73.8% 
BIS no 
BIS 
Count 1969 889 2858 
% within 
New_groups 
68.9% 31.1% 100.0% 
% within 
AAMAC_0.5_yn 
25.8% 27.3% 26.2% 
% of Total 18.1% 8.2% 26.2% 
Total 
Count 7642 3252 10894 
% within 
New_groups 
70.1% 29.9% 100.0% 
% within 
AAMAC_0.5_yn 
100.0% 100.0% 100.0% 
% of Total 70.1% 29.9% 100.0% 
 
 
 
 
159 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 2.911a 1 .088   
Continuity Correctionb 2.831 1 .092   
Likelihood Ratio 2.897 1 .089   
Fisher's Exact Test    .091 .046 
Linear-by-Linear 
Association 
2.911 1 .088 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 853.15. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.084 .988 1.189 
For cohort AAMAC_0.5_yn = No 
AAMAC<0.5 alerts 
1.025 .996 1.054 
For cohort AAMAC_0.5_yn = 1+ 
AAMAC <0.5 alerts 
.945 .887 1.008 
N of Valid Cases 10894   
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New_groups * AAMAC_0.6_yn 
Crosstab 
 AAMAC_0.6_yn Total 
No AAMAC<0.6 
alerts 
1+ AAMAC <0.6 
alerts 
New_group
s 
MAC 
Count 4759 3277 8036 
% within 
New_groups 
59.2% 40.8% 100.0% 
% within 
AAMAC_0.6_yn 
74.0% 73.4% 73.8% 
% of Total 43.7% 30.1% 73.8% 
BIS no 
BIS 
Count 1672 1186 2858 
% within 
New_groups 
58.5% 41.5% 100.0% 
% within 
AAMAC_0.6_yn 
26.0% 26.6% 26.2% 
% of Total 15.3% 10.9% 26.2% 
Total 
Count 6431 4463 10894 
% within 
New_groups 
59.0% 41.0% 100.0% 
% within 
AAMAC_0.6_yn 
100.0% 100.0% 100.0% 
% of Total 59.0% 41.0% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .450a 1 .502   
Continuity Correctionb .421 1 .517   
Likelihood Ratio .450 1 .502   
Fisher's Exact Test    .507 .258 
Linear-by-Linear 
Association 
.450 1 .502 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 1170.85. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.030 .945 1.123 
For cohort AAMAC_0.6_yn = No 
AAMAC<0.6 alerts 
1.012 .977 1.049 
For cohort AAMAC_0.6_yn = 1+ 
AAMAC <0.6 alerts 
.983 .934 1.034 
N of Valid Cases 10894   
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New_groups * AAMAC_0.7_yn 
Crosstab 
 AAMAC_0.7_yn Total 
No AAMAC<0.7 
alerts 
1+ AAMAC <0.7 
alerts 
New_group
s 
MAC 
Count 3653 4383 8036 
% within 
New_groups 
45.5% 54.5% 100.0% 
% within 
AAMAC_0.7_yn 
73.9% 73.7% 73.8% 
% of Total 33.5% 40.2% 73.8% 
BIS no 
BIS 
Count 1293 1565 2858 
% within 
New_groups 
45.2% 54.8% 100.0% 
% within 
AAMAC_0.7_yn 
26.1% 26.3% 26.2% 
% of Total 11.9% 14.4% 26.2% 
Total 
Count 4946 5948 10894 
% within 
New_groups 
45.4% 54.6% 100.0% 
% within 
AAMAC_0.7_yn 
100.0% 100.0% 100.0% 
% of Total 45.4% 54.6% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .040a 1 .842   
Continuity Correctionb .032 1 .859   
Likelihood Ratio .040 1 .842   
Fisher's Exact Test    .844 .429 
Linear-by-Linear 
Association 
.040 1 .842 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 1297.56. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.009 .926 1.099 
For cohort AAMAC_0.7_yn = No 
AAMAC<0.7 alerts 
1.005 .959 1.053 
For cohort AAMAC_0.7_yn = 1+ 
AAMAC <0.7 alerts 
.996 .958 1.035 
N of Valid Cases 10894   
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New_groups * AAMAC_0.8_yn 
Crosstab 
 AAMAC_0.8_yn Total 
No AAMAC<0.8 
alerts 
1+ AAMAC <0.8 
alerts 
New_group
s 
MAC 
Count 2460 5576 8036 
% within 
New_groups 
30.6% 69.4% 100.0% 
% within 
AAMAC_0.8_yn 
74.1% 73.6% 73.8% 
% of Total 22.6% 51.2% 73.8% 
BIS no 
BIS 
Count 859 1999 2858 
% within 
New_groups 
30.1% 69.9% 100.0% 
% within 
AAMAC_0.8_yn 
25.9% 26.4% 26.2% 
% of Total 7.9% 18.3% 26.2% 
Total 
Count 3319 7575 10894 
% within 
New_groups 
30.5% 69.5% 100.0% 
% within 
AAMAC_0.8_yn 
100.0% 100.0% 100.0% 
% of Total 30.5% 69.5% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .308a 1 .579   
Continuity Correctionb .282 1 .595   
Likelihood Ratio .308 1 .579   
Fisher's Exact Test    .586 .298 
Linear-by-Linear 
Association 
.308 1 .579 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 870.73. 
b. Computed only for a 2x2 table 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.027 .936 1.127 
For cohort AAMAC_0.8_yn = No 
AAMAC<0.8 alerts 
1.019 .955 1.087 
For cohort AAMAC_0.8_yn = 1+ 
AAMAC <0.8 alerts 
.992 .965 1.020 
N of Valid Cases 10894   
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New_groups * AAMAC_0.9_yn 
Crosstab 
 AAMAC_0.9_yn Total 
No AAMAC<0.9 
alerts 
1+ AAMAC <0.9 
alerts 
New_group
s 
MAC 
Count 1433 6603 8036 
% within 
New_groups 
17.8% 82.2% 100.0% 
% within 
AAMAC_0.9_yn 
73.8% 73.8% 73.8% 
% of Total 13.2% 60.6% 73.8% 
BIS no 
BIS 
Count 509 2349 2858 
% within 
New_groups 
17.8% 82.2% 100.0% 
% within 
AAMAC_0.9_yn 
26.2% 26.2% 26.2% 
% of Total 4.7% 21.6% 26.2% 
Total 
Count 1942 8952 10894 
% within 
New_groups 
17.8% 82.2% 100.0% 
% within 
AAMAC_0.9_yn 
100.0% 100.0% 100.0% 
% of Total 17.8% 82.2% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .001a 1 .978   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .001 1 .978   
Fisher's Exact Test    .999 .501 
Linear-by-Linear 
Association 
.001 1 .978 
  
N of Valid Cases 10894     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 509.48. 
b. Computed only for a 2x2 table 
 
 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for New_groups (MAC / 
BIS no BIS) 
1.002 .896 1.120 
For cohort AAMAC_0.9_yn = No 
AAMAC<0.9 alerts 
1.001 .914 1.097 
For cohort AAMAC_0.9_yn = 1+ 
AAMAC <0.9 alerts 
1.000 .980 1.020 
N of Valid Cases 10894   
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USE ALL. 
COMPUTE filter_$=(New_groups = 1). 
VARIABLE LABELS filter_$ 'New_groups = 1 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=quarter_org Percent_case_actual_alerted DISPLAY=LABEL 
  /TABLE quarter_org BY Percent_case_actual_alerted [MEAN, SEMEAN] 
  /CATEGORIES VARIABLES=quarter_org ORDER=A KEY=VALUE EMPTY=EXCLUDE. 
 
Table 1 
 Percent_case_actual_alerted 
Mean Standard Error of 
Mean 
quarter_org 
1 2.3247 .2532 
2 2.3491 .2201 
3 1.8286 .1830 
4 1.9109 .1375 
5 2.2568 .1981 
6 2.5781 .2420 
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7 2.5031 .2652 
8 3.7266 .3937 
 
GRAPH 
  /ERRORBAR(STERROR 2)=Percent_case_actual_alerted BY quarter_org. 
MAC only actual alerting 
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GRAPH 
  /ERRORBAR(STERROR 2)=Percent_BIS_60 BY quarter_org. 
 
BIS alerting 
 
 
* Custom Tables. 
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CTABLES 
  /VLABELS VARIABLES=quarter_org Percent_BIS_60 DISPLAY=LABEL 
  /TABLE quarter_org [C] BY Percent_BIS_60 [MEAN, SEMEAN] 
  /CATEGORIES VARIABLES=quarter_org ORDER=A KEY=VALUE EMPTY=EXCLUDE. 
Table 1 
 Percent_BIS_60 
Mean Standard Error of 
Mean 
quarter_org 
1 4.10 .52 
2 3.48 .41 
3 4.28 .47 
4 3.04 .35 
5 3.23 .33 
6 3.25 .34 
7 3.98 .36 
8 3.57 .36 
 
FILTER OFF. 
USE ALL. 
EXECUTE. 
USE ALL. 
COMPUTE filter_$=(New_groups = 1 OR New_groups = 3). 
VARIABLE LABELS filter_$ 'New_groups = 1 OR New_groups = 3 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
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FILTER BY filter_$. 
EXECUTE. 
GRAPH 
  /ERRORBAR(STERROR 2)=Percent_case_actual_alerted BY quarter_org 
  /PANEL COLVAR=New_groups COLOP=CROSS. 
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GRAPH 
  /ERRORBAR(STERROR 2)=Percent_case_actual_alerted BY quarter_org BY New_groups. 
 
 
FILTER OFF. 
USE ALL. 
EXECUTE. 
DATASET ACTIVATE DataSet1. 
SAVE OUTFILE='D:\amysha\Desktop\MACS '+ 
    'alerting\BIS_dissertation_merged_with_deletions_NO_PROPOFOL_INFUSIONS_21Aug12.sav' 
 /COMPRESSED. 
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USE ALL. 
COMPUTE filter_$=(New_groups = 1 OR  New_groups = 3). 
VARIABLE LABELS filter_$ 'New_groups = 1 OR  New_groups = 3 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Percent_case_actual_alerted) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
Nonparametric Tests 
 
USE ALL. 
COMPUTE filter_$=(New_groups = 1 OR  New_groups = 3). 
VARIABLE LABELS filter_$ 'New_groups = 1 OR  New_groups = 3 (FILTER)'. 
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VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
* Custom Tables. 
CTABLES 
  /VLABELS VARIABLES=New_groups quarter_org Percent_case_actual_alerted DISPLAY=LABEL 
  /TABLE New_groups > quarter_org BY Percent_case_actual_alerted [MEAN] 
  /CATEGORIES VARIABLES=New_groups ORDER=A KEY=VALUE EMPTY=INCLUDE 
  /CATEGORIES VARIABLES=quarter_org ORDER=A KEY=VALUE EMPTY=EXCLUDE. 
 
Custom Tables 
Table 1 
 Percent_case_actual_
alerted 
Mean 
New_groups MAC quarter_org 
1 2.3247 
2 2.3491 
3 1.8286 
4 1.9109 
5 2.2568 
6 2.5781 
7 2.5031 
8 3.7266 
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BIS with BIS quarter_org 
1 . 
2 . 
3 . 
4 . 
5 . 
6 . 
7 . 
8 . 
BIS no BIS quarter_org 
1 3.0432 
2 2.5724 
3 2.7104 
4 3.3431 
5 3.0498 
6 3.6249 
7 3.0340 
8 3.2933 
 
FILTER OFF. 
USE ALL. 
EXECUTE. 
SORT CASES  BY quarter_org. 
SPLIT FILE LAYERED BY quarter_org. 
USE ALL. 
COMPUTE filter_$=(New_groups = 1 OR  New_groups = 3). 
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VARIABLE LABELS filter_$ 'New_groups = 1 OR  New_groups = 3 (FILTER)'. 
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. 
FORMATS filter_$ (f1.0). 
FILTER BY filter_$. 
EXECUTE. 
 
*Nonparametric Tests: Independent Samples. 
NPTESTS 
  /INDEPENDENT TEST (Percent_case_actual_alerted) GROUP (New_groups) 
  /MISSING SCOPE=ANALYSIS USERMISSING=EXCLUDE 
  /CRITERIA ALPHA=0.05  CILEVEL=95. 
 
quarter_org = 1 
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quarter_org = 2 
 
quarter_org = 3 
 
quarter_org = 4 
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quarter_org = 5 
 
quarter_org = 6 
 
quarter_org = 7 
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quarter_org = 8 
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ABSTRACT 
NOVEL INCORPORATION OF BIOMEDICAL ENGINEERING 
ALGORITHMS (BISPECTRAL INDEX GUIDED OR ANESTHETIC 
CONCENTRATION GUIDED) IN REAL-TIME DECISION SUPPORT TO 
PREVENT INTRAOPERATIVE AWARENESS USING AN ELECTRONIC 
ANESTHESIA INFORMATION MANAGEMENT SYSTEM 
by 
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Advisors: Drs. John M. Cavanaugh and George A. Mashour 
Major: Biomedical Engineering 
Degree: Doctor of Philosophy 
Background: Intraoperative awareness with explicit recall (AWR) is a feared 
complication of surgery that can lead to significant psychological distress.  Several large 
prospective trials have been completed comparing two methods of monitoring anesthetic depth 
[minimum alveolar concentration (MAC) or electroencephalography (EEG) monitoring using the 
bispectral index (BIS)] for the prevention of AWR.  However, these trials were conducted in 
high risk populations, limiting generalizability. 
Research Hypothesis: Real-time decision support with Anesthesia Information 
Management System alerts based on a novel anesthetic concentration algorithm (incorporating 
the use of intravenous anesthetics) or an EEG-guided algorithm will reduce the known incidence 
of AWR. 
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Methods:  First, a MAC-equivalent alerting algorithm that incorporates the use of 
intravenous anesthetics was developed and retrospectively applied to previously collected data.  
A threshold was calculated that demonstrated optimal sensitivity and specificity for detecting 
AWR.  Next, a large prospective randomized controlled trial was performed in an unselected 
surgical population to compare the MAC-equivalent or a BIS alerting algorithm for the 
prevention of AWR.  Finally, discrete intraoperative data collected during that trial were 
analyzed to determine which specific threshold for MAC or BIS demonstrated optimal sensitivity 
and specificity in the eradication of AWR. 
Results:  Retrospective analysis revealed that a MAC-equivalent of <0.5 was associated 
with the highest positive likelihood ratio; this was used as the threshold in the prospective trial.  
No difference was detected between BIS or MAC-equivalent alerting algorithms in the reduction 
of AWR.  Post hoc analysis revealed that BIS, when compared to routine clinical care without 
alerts, demonstrated a 4.7 fold reduction in definite or possible AWR.  By secondary analysis, 
neither MAC nor BIS demonstrated a discrete population-based threshold with optimal 
sensitivity and specificity in the prevention of AWR.   
Conclusion:  No difference was detected in the reduction of AWR between BIS or MAC 
alerting.  However, BIS alerting when compared to standard of care reduced the incidence of 
AWR.   There were no discriminating thresholds of MAC or BIS values at the population level 
associated with the eradication of AWR.  In conclusion, real-time decision support reduces the 
incidence of AWR but individualized patient-based alerting algorithms will be required for its 
eradication. .   
  
 
200 
 
AUTOBIOGRAPHICAL STATEMENT 
Amy received her Bachelors of Science in Physiology from Michigan State University in 
May 1999.  Several months later, her professional career started at the University of Michigan 
Health System (UMHS) in the Department of Anesthesiology as a clinical research assistant.  
During her pursuit of her doctorate degree, Amy has continuously worked full-time at UMHS.  
She completed her Master’s Degree in Biomedical Engineering at Wayne State University from 
2001-2003.  Amy started her doctoral work in the Fall of 2004 in Biomedical Engineering at 
Wayne State University and has actively pursued completion while continuing to grow her career 
at UMHS.   
During her tenure at UMHS, Amy has transitioned from clinical research assistant, to 
clinical research manager, before moving onto becoming an integral team member that 
developed and executed the clinical outcomes research infrastructure using UMHS’ Anesthesia 
Information System (AIMS).  The Department of Anesthesiology is recognized globally for their 
perioperative outcomes research using AIMS data and over the past several years has developed 
the Multicenter Perioperative Outcomes Group (MPOG).   Amy currently serves as the Research 
Director of MPOG under the direction of Drs. Sachin Kheterpal and Kevin K. Tremper.  She also 
serves as the lead of the Statistics Core in the Department of Anesthesiology and has been an 
author on 53 peer-reviewed articles. 
 
 
